<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9943674</article-id>
    <article-id pub-id-type="pmid">36533448</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkac1157</article-id>
    <article-id pub-id-type="publisher-id">gkac1157</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>Narese/7</subject>
        <subject>Narese/24</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Methods Online</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>DRAGON: Determining Regulatory Associations using Graphical models on multi-Omic Networks</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Shutta</surname>
          <given-names>Katherine H</given-names>
        </name>
        <aff><institution>Department of Biostatistics, Harvard T.H. Chan School of Public Health</institution>, Boston, MA, <country country="US">USA</country></aff>
        <aff><institution>Channing Division of Network Medicine, Brigham and Women’s Hospital, and Department of Medicine, Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4979-5871</contrib-id>
        <name>
          <surname>Weighill</surname>
          <given-names>Deborah</given-names>
        </name>
        <aff><institution>Department of Biostatistics, Harvard T.H. Chan School of Public Health</institution>, Boston, MA, <country country="US">USA</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Burkholz</surname>
          <given-names>Rebekka</given-names>
        </name>
        <aff><institution>CISPA Helmholtz Center for Information Security</institution>, Saarbrücken, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5934-966X</contrib-id>
        <name>
          <surname>Guebila</surname>
          <given-names>Marouen Ben</given-names>
        </name>
        <aff><institution>Department of Biostatistics, Harvard T.H. Chan School of Public Health</institution>, Boston, MA, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>DeMeo</surname>
          <given-names>Dawn L</given-names>
        </name>
        <aff><institution>Channing Division of Network Medicine, Brigham and Women’s Hospital, and Department of Medicine, Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zacharias</surname>
          <given-names>Helena U</given-names>
        </name>
        <aff><institution>Department of Internal Medicine I, University Medical Center Schleswig-Holstein</institution>, Campus Kiel, Kiel, <country country="DE">Germany</country></aff>
        <aff><institution>Institute of Clinical Molecular Biology, Kiel University and University Medical Center Schleswig-Holstein</institution>, Campus Kiel, Kiel, <country country="DE">Germany</country></aff>
        <aff><institution>Peter L. Reichertz Institute for Medical Informatics of TU Braunschweig and Hannover Medical School</institution>, Hannover, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2702-5879</contrib-id>
        <name>
          <surname>Quackenbush</surname>
          <given-names>John</given-names>
        </name>
        <aff><institution>Department of Biostatistics, Harvard T.H. Chan School of Public Health</institution>, Boston, MA, <country country="US">USA</country></aff>
        <aff><institution>Channing Division of Network Medicine, Brigham and Women’s Hospital, and Department of Medicine, Harvard Medical School</institution>, Boston, MA, <country country="US">USA</country></aff>
        <xref rid="FN2" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1102-6532</contrib-id>
        <name>
          <surname>Altenbuchinger</surname>
          <given-names>Michael</given-names>
        </name>
        <!--michael.altenbuchinger@bioinf.med.uni-goettingen.de-->
        <aff><institution>Department of Biostatistics, Harvard T.H. Chan School of Public Health</institution>, Boston, MA, <country country="US">USA</country></aff>
        <aff><institution>Department of Medical Bioinformatics, University Medical Center Göttingen</institution>, Göttingen, <country country="DE">Germany</country></aff>
        <xref rid="FN2" ref-type="author-notes"/>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +49 551 39 61788; Fax: +49 551 39 61783; Email: <email>michael.altenbuchinger@bioinf.med.uni-goettingen.de</email></corresp>
      <fn id="FN1">
        <p>The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.</p>
      </fn>
      <fn id="FN2">
        <p>John Quackenbush and Michael Altenbuchinger, shared senior authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <day>22</day>
      <month>2</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-12-19">
      <day>19</day>
      <month>12</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>19</day>
      <month>12</month>
      <year>2022</year>
    </pub-date>
    <volume>51</volume>
    <issue>3</issue>
    <fpage>e15</fpage>
    <lpage>e15</lpage>
    <history>
      <date date-type="accepted">
        <day>23</day>
        <month>11</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>08</day>
        <month>11</month>
        <year>2022</year>
      </date>
      <date date-type="received">
        <day>19</day>
        <month>7</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkac1157.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>The increasing quantity of multi-omic data, such as methylomic and transcriptomic profiles collected on the same specimen or even on the same cell, provides a unique opportunity to explore the complex interactions that define cell phenotype and govern cellular responses to perturbations. We propose a network approach based on Gaussian Graphical Models (GGMs) that facilitates the joint analysis of paired omics data. This method, called DRAGON (Determining Regulatory Associations using Graphical models on multi-Omic Networks), calibrates its parameters to achieve an optimal trade-off between the network’s complexity and estimation accuracy, while explicitly accounting for the characteristics of each of the assessed omics ‘layers.’ In simulation studies, we show that DRAGON adapts to edge density and feature size differences between omics layers, improving model inference and edge recovery compared to state-of-the-art methods. We further demonstrate in an analysis of joint transcriptome - methylome data from TCGA breast cancer specimens that DRAGON can identify key molecular mechanisms such as gene regulation via promoter methylation. In particular, we identify Transcription Factor AP-2 Beta (TFAP2B) as a potential multi-omic biomarker for basal-type breast cancer. DRAGON is available as open-source code in Python through the Network Zoo package (netZooPy v0.8; netzoo.github.io).</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health</institution>
            <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>2T32HL007427</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Cancer Institute</institution>
            <institution-id institution-id-type="DOI">10.13039/100000054</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>1R35CA220523</award-id>
        <award-id>1U24CA231846</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Institutes of Health</institution>
            <institution-id institution-id-type="DOI">10.13039/100000002</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>R01HG011393</award-id>
        <award-id>P01114501</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>German Federal Ministry of Education and Research</institution>
          </institution-wrap>
        </funding-source>
        <award-id>01ZX1912A</award-id>
        <award-id>01ZX1912C</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="14"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Many biological systems can be visualized using networks, where biologically relevant elements are represented as nodes and relationships between those elements are represented as edges. Examples include gene regulatory networks, which represent the regulation of genes by transcription factors, and protein–protein interaction networks, which capture physical interactions between proteins (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>). Network models can be based on prior knowledge (<xref rid="B3" ref-type="bibr">3</xref>), inferred from data (<xref rid="B4" ref-type="bibr">4</xref>), or combinations thereof (<xref rid="B5" ref-type="bibr">5</xref>). Here, we focus on data-driven network inference from high-throughput multi-omic data. In this context, co-expression networks (<xref rid="B6" ref-type="bibr">6</xref>), which are based on a measure of correlation such as Pearson’s correlation, are often used to capture potential associations between biomolecules that may be coordinately altered in specific biological states. However, a major drawback of such networks is that they do not distinguish direct from indirect effects (<xref rid="B7" ref-type="bibr">7</xref>). For example, consider a situation where a transcription factor <italic toggle="yes">A</italic> regulates the expression of two genes, <italic toggle="yes">B</italic> and <italic toggle="yes">C</italic>. In this case, a correlation network will contain an edge between gene <italic toggle="yes">B</italic> and gene <italic toggle="yes">C</italic> because correlation indicates a relation between the two genes. However, that relationship is only a consequence of their mutual relationship with the transcription factor <italic toggle="yes">A</italic> and thus the observed edge in the correlation network represents an indirect association. The problem of such erroneous correlations was discussed by Pearson and Yule in the early twentieth century, where the term ‘spurious correlation’ was introduced to distinguish indirect from direct relationships; a historical review of this question has been summarized by Aldrich and colleagues (<xref rid="B8" ref-type="bibr">8</xref>).</p>
    <p>Several approaches have attempted to address this issue (<xref rid="B9" ref-type="bibr">9–12</xref>), of which Gaussian graphical models (GGMs; also known as partial correlation networks) (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>) are among the most widely used methods. In a GGM, edges represent partial correlations. Intuitively, the partial correlation between two variables can be considered as the correlation that takes into account the effect of all remaining variables in the data set. Thus, it can distinguish a direct relationship from one that is mediated by one or more other variables. GGMs outperform simple correlation networks (<xref rid="B13" ref-type="bibr">13</xref>) and were consistently among the best in comparison to other methods in finding meaningful associations (<xref rid="B14" ref-type="bibr">14</xref>).</p>
    <p>A single type of omics data generally only provides part of the information necessary to distinguish between direct and incidental relationships. For example, we know that gene regulation is a process that involves multiple layers of control, including transcription factor binding, epigenetic regulation, and chromatin structure. However, many analyses incorporate only gene expression data and not other regulatory data. Incorporating data from multiple omics could help prevent possibly erroneous conclusions based on the concept of spurious correlations introduced above.</p>
    <p>New technologies are making it possible to generate multiple layers of omics data from the same samples. For example, The Cancer Genome Atlas (TCGA) provides data on RNA expression, methylation levels, and copy number variations for many individual tumor samples. More recently, single cell multi-omic data have become available as it has become possible to assay different omics data types from individual cells; for example, Cao <italic toggle="yes">et al.</italic> measured RNA and chromatin accessibility in single cells (<xref rid="B15" ref-type="bibr">15</xref>). Such multifactorial data will allow us to better disentangle interactions between biological variables and distinguish genuine from spurious associations.</p>
    <p>Most omics data are high dimensional, meaning that the number of measured variables <italic toggle="yes">p</italic> typically exceeds the number of samples <italic toggle="yes">n</italic> (or both are of the same order of magnitude), which presents challenges for network inference (<xref rid="B7" ref-type="bibr">7</xref>). Several remedies have been proposed based on regularization techniques from high-dimensional statistics (<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref>). Multi-omic network inference is complicated by a number of factors including the larger numbers of variables, different numbers of variables for each omics layer, variable noise levels within and between layers, and different edge densities in each data type.</p>
    <p>In this work, we propose DRAGON, a machine learning method to estimate GGMs using two omics layers simultaneously. DRAGON calibrates omic-specific hyper-parameters for each omic layer to achieve an optimal trade-off between model complexity and estimation accuracy while explicitly taking into account the unique characteristics of each omics layer.</p>
    <p>We show in simulations that DRAGON adapts to differences in edge densities and feature sizes of the included omics layers. Finally, we use DRAGON to analyze joint transcriptome–methylome data from TCGA breast cancer specimens. The latter analysis shows that DRAGON can identify potential regulatory molecular mechanisms, such as the association between promoter methylation and gene expression. We further show that DRAGON can identify multi-omic biomarkers, as exemplified by the combination of promoter methylation and gene-expression of TFAP2B (Transcription Factor AP-2 Beta), which is strongly associated with the basal-like breast cancer subtype.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>MATERIALS AND METHODS</title>
    <sec id="SEC2-1">
      <title>The Gaussian Graphical Model</title>
      <p>Let <italic toggle="yes">X</italic> be a <italic toggle="yes">n</italic> × <italic toggle="yes">p</italic> data matrix of <italic toggle="yes">n</italic> observations (samples) and <italic toggle="yes">p</italic> features (such as genes, methylated sites, or proteins). Assume that the observations <inline-formula><tex-math id="M0001" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\mathbf {x}_1,\mathbf {x}_2,\ldots , \mathbf {x}_n \in \mathbb {R}^p$\end{document}</tex-math></inline-formula> are independent and identically distributed according to a multivariate normal, <italic toggle="yes">N</italic>(μ, Σ), where Σ is a positive definite covariance matrix. Further, Θ = (θ<sub><italic toggle="yes">ij</italic></sub>) = Σ<sup>−1</sup> is the inverse covariance matrix (also called precision matrix) where vanishing entries <inline-formula><tex-math id="M0001a" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\theta_{ij} = 0$\end{document}</tex-math></inline-formula> correspond to conditional independencies between variables <italic toggle="yes">i</italic> and <italic toggle="yes">j</italic>. A Gaussian Graphical Model (GGM) is a conditional dependence graph in which nodes represent variables and edges connect conditionally dependent pairs of variables (<xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B19" ref-type="bibr">19</xref>).</p>
      <p>Let <inline-formula><tex-math id="M0002" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\mathcal{S}_n=\frac{1}{n}\sum _{i=1}^n(\mathbf {x}_i-\hat{\mu })(\mathbf {x}_i-\hat{\mu })^T$\end{document}</tex-math></inline-formula> be the sample covariance matrix, where <inline-formula><tex-math id="M0003" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\hat{\mu }=\frac{1}{n}\sum _{i=1}^n \mathbf {x}_i$\end{document}</tex-math></inline-formula> is the sample mean. Then, the corresponding log likelihood takes the form<disp-formula id="M1"><label>(1)</label><tex-math id="M0004" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*} l({\Theta })= \frac{n}{2}\left(\log |{\Theta }|-\operatorname{Tr}\left(\mathcal{S}_n{\Theta }\right)\right). \end{equation*}$$\end{document}</tex-math></disp-formula></p>
    </sec>
    <sec id="SEC2-2">
      <title>Covariance shrinkage</title>
      <p>The maximum likelihood estimate (MLE) of Equation (<xref rid="M1" ref-type="disp-formula">1</xref>) yields <inline-formula><tex-math id="M0005" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\hat{\Theta } = \mathcal{S}_n^{-1}$\end{document}</tex-math></inline-formula>. However, if the number of features <italic toggle="yes">p</italic> exceeds the number of independent observations <italic toggle="yes">n</italic>, then <inline-formula><tex-math id="M0006" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\mathcal S_n$\end{document}</tex-math></inline-formula> is singular and cannot be inverted. Even if <italic toggle="yes">p</italic> is smaller than <italic toggle="yes">n</italic> but of the same order of magnitude, <inline-formula><tex-math id="M0007" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\hat{\Theta }$\end{document}</tex-math></inline-formula> has a high variance. One way this issue is often addressed is by adding regularization terms to Equation (<xref rid="M1" ref-type="disp-formula">1</xref>), as for example proposed in (<xref rid="B17" ref-type="bibr">17</xref>). Another approach is that of Schäfer <italic toggle="yes">et al.</italic> (<xref rid="B12" ref-type="bibr">12</xref>), who bias the covariance matrix towards a target matrix that is typically full-rank. Such ‘covariance shrinkage’ is based on the biased estimator<disp-formula id="M2"><label>(2)</label><tex-math id="M0008" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*} {\hat{\Theta }} = \left((1-\lambda ){S}+\lambda {T}\right)^{-1}\, , \end{equation*}$$\end{document}</tex-math></disp-formula>where <inline-formula><tex-math id="M0009" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$S = \frac{1}{n-1}\sum_{i=1}^n(\mathbf{x}_i - \hat{\mu})(\mathbf{x}_i - \hat{\mu})^T = \frac{n}{n-1}\mathcal{S}_n$\end{document}</tex-math></inline-formula> is the unbiased empirical covariance, λ ∈ [0, 1] is a regularization parameter that can be estimated using the Lemma of Ledoit and Wolf (<xref rid="B20" ref-type="bibr">20</xref>) and <italic toggle="yes">T</italic> is the target matrix. Here, different choices for <italic toggle="yes">T</italic> have been proposed, such as the identity, <italic toggle="yes">T</italic> = <italic toggle="yes">I</italic><sub><italic toggle="yes">p</italic></sub>, and the diagonal of <italic toggle="yes">S</italic>, <inline-formula><tex-math id="M00010" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${T}=\operatorname{diag}(s_{11},s_{22},\ldots ,s_{pp})$\end{document}</tex-math></inline-formula>. The idea behind Equation (<xref rid="M2" ref-type="disp-formula">2</xref>) is to replace the unbiased empirical covariance <italic toggle="yes">S</italic> with a linear combination of <italic toggle="yes">S</italic> and the target matrix <italic toggle="yes">T</italic> representing conditional independence. Because <italic toggle="yes">T</italic> is full-rank, the singularity of <italic toggle="yes">S</italic> is mitigated in this sum. Consequently, a biased precision matrix estimator can be obtained from inverting the shrunken covariance matrix. Throughout this article, we use the target matrix <inline-formula><tex-math id="M00011" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${T}=\operatorname{diag}(s_{11},s_{22},\ldots ,s_{pp})$\end{document}</tex-math></inline-formula> following the arguments in (<xref rid="B12" ref-type="bibr">12</xref>).</p>
    </sec>
    <sec id="SEC2-3">
      <title>DRAGON</title>
      <sec id="SEC2-3-1">
        <title>Generalized covariance shrinkage</title>
        <p>In DRAGON, we extend covariance shrinkage to account for two different omics layers by introducing layer-specific regularization terms. Let <italic toggle="yes">X</italic><sup>(1)</sup> be a <italic toggle="yes">n</italic> × <italic toggle="yes">p</italic><sub>1</sub> data matrix that represents the first omics layer and let <italic toggle="yes">X</italic><sup>(2)</sup> be a <italic toggle="yes">n</italic> × <italic toggle="yes">p</italic><sub>2</sub> data matrix for the second layer, where <italic toggle="yes">p</italic><sub>1</sub> and <italic toggle="yes">p</italic><sub>2</sub> are the number of variables from omics layers 1 and 2. We further assume paired data, meaning that measurements (rows) <inline-formula><tex-math id="M00012" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\mathbf {x}_i^{(1)}$\end{document}</tex-math></inline-formula> and <inline-formula><tex-math id="M00013" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\mathbf {x}_i^{(2)}$\end{document}</tex-math></inline-formula> correspond to the same sample <italic toggle="yes">i</italic> but differ in their features. We define the empirical sample covariances <inline-formula><tex-math id="M00014" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$S^{(k, l)}=\frac{1}{n-1}\sum _{i=1}^n(\mathbf {x}_i^{(k)}-{\hat{\mu }}^{(k)})(\mathbf {x}_i^{(l)}-{\hat{\mu }}^{(l)})^T$\end{document}</tex-math></inline-formula> with the empirical mean vector <inline-formula><tex-math id="M00015" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\hat{\mu }^{(k)}=\frac{1}{n}\sum _{i=1}^n \mathbf {x}_i^{(k)}$\end{document}</tex-math></inline-formula> for <italic toggle="yes">k</italic>, <italic toggle="yes">l</italic> ∈ {1, 2}. Now, we can generalize the shrinkage estimator to<disp-formula id="M3"><label>(3)</label><tex-math id="M00016" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{eqnarray*} {\hat{\Theta }}&amp;=&amp;\Bigg (\begin{pmatrix}(1-\lambda _1) {S}^{(1,1)}&amp;\sqrt{1-\lambda _1}\sqrt{1-\lambda _2} S^{(1,2)}\nonumber \\ \sqrt{1-\lambda _1}\sqrt{1-\lambda _2} S^{(2,1)}&amp;(1-\lambda _2) S^{(2,2)} \end{pmatrix}\nonumber \\ &amp;&amp;+\begin{pmatrix}\lambda _1 T^{(1)}&amp;0\\ 0&amp;\lambda _2 T^{(2)}\end{pmatrix}\Bigg )^{-1}\, , \end{eqnarray*}$$\end{document}</tex-math></disp-formula>with λ<sub><italic toggle="yes">k</italic></sub> ∈ [0, 1] and <inline-formula><tex-math id="M00017" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${T}^{(k)} = \rm {diag}(s^{(k)}_{11}, s^{(k)}_{22}, \ldots , s^{(k)}_{p_k p_k})$\end{document}</tex-math></inline-formula>, where <inline-formula><tex-math id="M00018" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${S}^{(k,k)}=(s^{(k)}_{ij})$\end{document}</tex-math></inline-formula>. For illustration purposes, we first consider the limit λ<sub>2</sub> = 1. Here, Equation (<xref rid="M3" ref-type="disp-formula">3</xref>) becomes<disp-formula id="M4"><label>(4)</label><tex-math id="M00019" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{eqnarray*} {\hat{\Theta }}&amp;=&amp;\left(\begin{pmatrix}(1-\lambda _1) S^{(1,1)}&amp;0\\ 0&amp;0 \end{pmatrix}+\begin{pmatrix}\lambda _1 T^{(1)}&amp;0\\ 0&amp; T^{(2)}\end{pmatrix}\right)^{-1}\nonumber \\ &amp;=&amp;\begin{pmatrix}\Theta ^{(1,1)}&amp;0\\ 0&amp;\left( T^{(2)}\right)^{-1} \end{pmatrix}\, , \end{eqnarray*}$$\end{document}</tex-math></disp-formula>where Θ<sup>(1, 1)</sup> = ((1 − λ<sub>1</sub>)<italic toggle="yes">S</italic><sup>(1, 1)</sup> + λ<sub>1</sub><italic toggle="yes">T</italic><sup>(1)</sup>)<sup>−1</sup> is the shrinkage estimator of the precision matrix using only the features with <italic toggle="yes">k</italic> = 1. Thus, if λ<sub>2</sub> = 1, technology 1 decouples from technology 2.</p>
        <p>Next, consider the limit λ<sub>1</sub> = λ<sub>2</sub> = λ. Then Equation (<xref rid="M3" ref-type="disp-formula">3</xref>) becomes<disp-formula id="M5"><label>(5)</label><tex-math id="M00020" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{eqnarray*} {\hat{\Theta }}&amp;=&amp;\left((1-\lambda )\begin{pmatrix}S^{(1,1)}&amp; S^{(1,2)}\\ S^{(2,1)}&amp; S^{(2,2)} \end{pmatrix}+\lambda \begin{pmatrix}T^{(1)}&amp;0\\ 0&amp; T^{(2)}\end{pmatrix}\right)^{-1}\nonumber \\ &amp;=&amp;\left((1-\lambda ) S+\lambda T\right)^{-1}\, . \end{eqnarray*}$$\end{document}</tex-math></disp-formula>Thus, we naively treat both omics layers as if they were generated using the same technology. These examples show that DRAGON naturally incorporates two limits that bound the optimal solution: (i) GGMs estimated for the two omics layers separately and (ii) a GGM treating both layers such as if they belong to the same layer.</p>
      </sec>
      <sec id="SEC2-3-2">
        <title>Generalization of the lemma of Ledoit and Wolf</title>
        <p>The penalty parameters λ<sub>1</sub> and λ<sub>2</sub> can be estimated using cross-validation or resampling; however, such approaches are computationally expensive. Alternatively, one can use an analytical estimate following the arguments of Ledoit &amp; Wolf (<xref rid="B20" ref-type="bibr">20</xref>). There, the shrinkage parameter λ was derived by minimizing<disp-formula id="M6"><label>(6)</label><tex-math id="M00021" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*} R=\operatorname{E}\!\left[|| {\hat{\Sigma }}-{\Sigma }||_F^2\right]\, \end{equation*}$$\end{document}</tex-math></disp-formula>with respect to λ, where <inline-formula><tex-math id="M00022" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\hat{\Sigma }}= (1-\lambda ){S} + \lambda {T}$\end{document}</tex-math></inline-formula> and Σ is the true, underlying covariance. This is possible since <inline-formula><tex-math id="M00023" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\operatorname{bias}({S}) = 0$\end{document}</tex-math></inline-formula> makes Equation (<xref rid="M6" ref-type="disp-formula">6</xref>) independent of Σ.</p>
        <p>Here, we extend this approach to the shrinkage formula (<xref rid="M3" ref-type="disp-formula">3</xref>) and estimate λ<sub>1</sub> and λ<sub>2</sub> by minimizing<disp-formula id="M7"><label>(7)</label><tex-math id="M00024" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*} \operatorname{E}\!\left[|| {\hat{\Sigma }}-{\Sigma }||_F^2\right]=\sum _{k,l=1}^2\operatorname{E}\!\left[|| {\hat{\Sigma }}^{(k,l)}-{{\Sigma }}^{(k,l)}||_F^2\right] \end{equation*}$$\end{document}</tex-math></disp-formula>with respect to λ<sub>1</sub> and λ<sub>2</sub>, where <inline-formula><tex-math id="M00025" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$|| \cdot ||_F$\end{document}</tex-math></inline-formula> is the Frobenius norm. Following the arguments in (<xref rid="B12" ref-type="bibr">12</xref>) (see Suppl. Section 1), we obtain<disp-formula id="M8"><label>(8)</label><tex-math id="M00026" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{eqnarray*} R&amp;=&amp;\operatorname{E}\!\left[|| {\hat{\Sigma }}-{\Sigma }||_F^2\right] \nonumber \\ &amp;=&amp;\rm {const.} + \lambda _1 T^{(1)}_{1}+ \lambda _2 T^{(2)}_{1}+ \lambda _1^2 T^{(1)}_{2}+ \lambda _2^2 T^{(2)}_{2} \nonumber \\ &amp;&amp;+ \lambda _1\lambda _2 T_{3}+ \sqrt{1-\lambda _1}\sqrt{1-\lambda _2}T_{4} \end{eqnarray*}$$\end{document}</tex-math></disp-formula>where the constant term is independent of λ<sub>1</sub> and λ<sub>2</sub>, and<disp-formula><tex-math id="M00027" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{eqnarray*} T^{(k)}_{1}&amp;=&amp;-2\left(\sum _{i\ne j}\operatorname{var}(s^{(k)}_{ij})+\sum _{i, j}\operatorname{E}((s^{(1,2)}_{ij})^2)\right)\, ,\nonumber \\ T^{(k)}_{2}&amp;=&amp;\sum _{i\ne j} \operatorname{E}((s^{(k)}_{ij})^2)\, ,\nonumber \\ T_3&amp;=&amp;2\sum _{i, j}\operatorname{E}((s^{(1,2)}_{ij})^2)\, ,\nonumber \\ T_4&amp;=&amp;4\sum _{i, j}\left(\operatorname{var}(s^{(1,2)}_{ij})-\operatorname{E}((s^{(1,2)}_{ij})^2)\right)\, \nonumber \end{eqnarray*}$$\end{document}</tex-math></disp-formula>Equation (<xref rid="M8" ref-type="disp-formula">8</xref>) can be easily minimized with respect to λ<sub>1</sub> ∈ [0, 1] and λ<sub>2</sub> ∈ [0, 1], where the moments can be estimated following (<xref rid="B12" ref-type="bibr">12</xref>).</p>
      </sec>
      <sec id="SEC2-3-3">
        <title>Hypotheses testing</title>
        <p>An estimate for the partial correlation between variable <italic toggle="yes">i</italic> and <italic toggle="yes">j</italic> can be directly obtained from <inline-formula><tex-math id="M00028" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\hat{\Theta }}=( \hat{\theta }_{ij})$\end{document}</tex-math></inline-formula> by calculating<disp-formula id="M9"><label>(9)</label><tex-math id="M00029" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*} \hat{\rho }_{ij} = -\frac{\hat{\theta }_{ij}}{\sqrt{\hat{\theta }_{ii}\hat{\theta }_{jj}}}\, . \end{equation*}$$\end{document}</tex-math></disp-formula>As a consequence of covariance shrinkage, the partial correlation matrix <inline-formula><tex-math id="M00030" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\hat{P}}=(\hat{\rho }_{ij})$\end{document}</tex-math></inline-formula> is also shrunken (<xref rid="B21" ref-type="bibr">21</xref>). Bernal et al. (2019) developed a null-model probability density that naturally accounts for this shrinkage effect (<xref rid="B21" ref-type="bibr">21</xref>):<disp-formula id="M10"><label>(10)</label><tex-math id="M00031" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*} f^\lambda _{0}(\rho )=\frac{\left((1-\lambda )^2-\rho ^2\right)^{(\kappa -3)/2}}{\rm {Beta}(\frac{1}{2},\frac{\kappa -1}{2}) (1-\lambda )^{\kappa -2}}\, , \end{equation*}$$\end{document}</tex-math></disp-formula>where the parameter <inline-formula><tex-math id="M00032" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\kappa$\end{document}</tex-math></inline-formula> is given by <italic toggle="yes">n</italic> − 1 − (<italic toggle="yes">p</italic> − 2) for <italic toggle="yes">n</italic> ≫ <italic toggle="yes">p</italic>, or can be fitted by MLE for the ill-posed case <italic toggle="yes">p</italic> &gt; <italic toggle="yes">n</italic> or for <italic toggle="yes">p</italic> ≈ <italic toggle="yes">n</italic> (<xref rid="B21" ref-type="bibr">21</xref>). For an intuitive derivation of Equation (<xref rid="M10" ref-type="disp-formula">10</xref>) see (<xref rid="B21" ref-type="bibr">21</xref>). Let<disp-formula id="M11"><label>(11)</label><tex-math id="M00033" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*} {\hat{\Theta }}=\begin{pmatrix}\hat{\Theta }^{(1,1)}&amp;{\hat{\Theta }}^{(1,2)}\\ {\hat{\Theta }}^{(2,1)}&amp;{\hat{\Theta }}^{(2,2)} \end{pmatrix}\quad {\rm and}\quad {\hat{P}}=\begin{pmatrix}\hat{P}^{(1,1)}&amp;{\hat{P}}^{(1,2)}\\ {\hat{P}}^{(2,1)}&amp;{\hat{P}}^{(2,2)} \end{pmatrix}\, , \end{equation*}$$\end{document}</tex-math></disp-formula>where <inline-formula><tex-math id="M00034" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\hat{\Theta }}^{(1,1)}$\end{document}</tex-math></inline-formula> (<inline-formula><tex-math id="M00035" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\hat{P}}^{(1,1)}$\end{document}</tex-math></inline-formula>) has dimension <italic toggle="yes">p</italic><sub>1</sub> × <italic toggle="yes">p</italic><sub>1</sub> and <inline-formula><tex-math id="M00036" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\hat{\Theta }}^{(2,2)}$\end{document}</tex-math></inline-formula> (<inline-formula><tex-math id="M00037" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\hat{P}}^{(2,2)}$\end{document}</tex-math></inline-formula>) dimension <italic toggle="yes">p</italic><sub>2</sub> × <italic toggle="yes">p</italic><sub>2</sub>. Then, DRAGON assigns significance levels to partial correlations using the following steps:</p>
        <list list-type="roman-lower">
          <list-item>
            <p>Simulate data under the null hypotheses (<italic toggle="yes">H</italic><sub>0</sub>: ρ = 0) for given sample size <italic toggle="yes">n</italic>, and estimate corresponding partial correlations using DRAGON with λ<sub>1</sub> and λ<sub>2</sub> given from the original data.</p>
          </list-item>
          <list-item>
            <p>Fit <inline-formula><tex-math id="M00038" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\kappa$\end{document}</tex-math></inline-formula> using MLE of Equation (<xref rid="M10" ref-type="disp-formula">10</xref>) for <italic toggle="yes">P</italic><sup>(1, 1)</sup>, <italic toggle="yes">P</italic><sup>(1, 2)</sup> and <italic toggle="yes">P</italic><sup>(2, 2)</sup>, separately.</p>
          </list-item>
          <list-item>
            <p>Use density Equation (<xref rid="M10" ref-type="disp-formula">10</xref>) with <inline-formula><tex-math id="M00039" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\kappa$\end{document}</tex-math></inline-formula> determined in (ii) to assign significance levels to <inline-formula><tex-math id="M00040" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\hat{P}}^{(1,1)}$\end{document}</tex-math></inline-formula>, <inline-formula><tex-math id="M00041" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\hat{P}}^{(1,2)}$\end{document}</tex-math></inline-formula>, <inline-formula><tex-math id="M00042" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\hat{P}}^{(2,2)}$\end{document}</tex-math></inline-formula>, respectively.</p>
          </list-item>
          <list-item>
            <p>Adjust significance levels in layer (1,1), (1,2) and (2,2) for multiple testing, separately, using the method of Benjamini and Hochberg (<xref rid="B22" ref-type="bibr">22</xref>). Note that if we control the false discovery rate (FDR) at level α in each layer, we also control the overall FDR at level α across all layers. However, to provide good estimates, <italic toggle="yes">p</italic><sub>1</sub> and <italic toggle="yes">p</italic><sub>2</sub> must be assumed to be sufficiently large.</p>
          </list-item>
        </list>
        <p>For <italic toggle="yes">n</italic> ≫ <italic toggle="yes">p</italic>, <inline-formula><tex-math id="M00043" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\kappa$\end{document}</tex-math></inline-formula> is given by <inline-formula><tex-math id="M00044" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\kappa$\end{document}</tex-math></inline-formula> = <italic toggle="yes">n</italic> − 1 − (<italic toggle="yes">p</italic> − 2) and (i–ii) are not necessary.</p>
      </sec>
    </sec>
    <sec id="SEC2-4">
      <title>Performance comparisons</title>
      <p>To benchmark the performance of DRAGON, we selected five methods for GGM estimation, each of which has distinct advantages and disadvantages (<xref rid="B7" ref-type="bibr">7</xref>), based on the requirement that they are available through a user-friendly software, provide estimates for <italic toggle="yes">p</italic>-values without computationally expensive resampling, and have been published in peer-reviewed journals.</p>
      <list list-type="bullet">
        <list-item>
          <p><bold>GGM:</bold> we implemented an omics-layer agnostic DRAGON model, which we simply denote as Gaussian Graphical Model (GGM) in the following. Note, in contrast to the GeneNet implementation described below (<xref rid="B23" ref-type="bibr">23</xref>), this approach uses the exact null distribution for shrunken partial correlations as suggested by (<xref rid="B21" ref-type="bibr">21</xref>).</p>
        </list-item>
        <list-item>
          <p><bold>GeneNet:</bold> the R-package ‘GeneNet’ (<xref rid="B23" ref-type="bibr">23</xref>) uses covariance shrinkage and provides estimates for adjusted <italic toggle="yes">p</italic>-values (<italic toggle="yes">q</italic>-values) via an empirical Bayes approach (<xref rid="B24" ref-type="bibr">24</xref>). We used the standard settings for all comparisons.</p>
        </list-item>
        <list-item>
          <p><bold>B-NW-SL:</bold> the bivariate nodewise scaled lasso was suggested by (<xref rid="B25" ref-type="bibr">25</xref>) and uses a regression approach to obtain asymptotically efficient estimates of the precision matrix under a sparseness condition relative to the sample size. We used the implementation provided in the ‘SILGGM’ R-package with standard settings.</p>
        </list-item>
        <list-item>
          <p><bold>D-S-NW-SL:</bold> the de-sparsified nodewise scaled lasso (<xref rid="B26" ref-type="bibr">26</xref>) uses a modification of the nodewise lasso regression approach suggested by (<xref rid="B16" ref-type="bibr">16</xref>) with a de-sparsified estimator. We used the ‘SILGGM’ R-package with standard settings.</p>
        </list-item>
        <list-item>
          <p><bold>D-S-GL:</bold> the de-sparsified graphical lasso was proposed by (<xref rid="B27" ref-type="bibr">27</xref>) and is based on a de-sparsified modification of the graphical lasso proposed by (<xref rid="B17" ref-type="bibr">17</xref>). We used the ‘SILGGM’ R-package with standard settings.</p>
        </list-item>
      </list>
      <p>For all methods except GeneNet, which provides adjusted <italic toggle="yes">p</italic>-values (<italic toggle="yes">q</italic>-values), we adjusted <italic toggle="yes">p</italic>-values using the procedure of Benjamini and Hochberg (<xref rid="B22" ref-type="bibr">22</xref>).</p>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC3">
    <title>RESULTS AND DISCUSSION</title>
    <sec id="SEC3-1">
      <title>Simulation studies</title>
      <p>We begin by briefly reviewing the concept of partial correlations and their relevance for multi-omics data analysis. Subsequently, we use four different simulation studies to show a comprehensive performance comparison between DRAGON and competing methods for GGM estimation.</p>
      <p>Multiple layers of interacting regulatory processes are involved in determining a cell’s state. By considering molecular variables of a single omic layer, such as the transcriptome, we can miss relevant information which might lead to erroneous conclusions about causal associations. To illustrate this effect, consider a scenario where the transcription of two genes, <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>, is regulated via the same molecular (<italic toggle="yes">regulator</italic>) ‘variable’. The <italic toggle="yes">regulator</italic> might belong to another omics layer representing a different biological factor such as the chromatin state in the DNA region of <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>. We generated artificial data representing such a process for <italic toggle="yes">n</italic> = 100 observations (Supplementary Section 2, Figure <xref rid="F1" ref-type="fig">1D</xref>), assuming a linear relationship between the observed level of the <italic toggle="yes">regulator</italic> and that of gene <italic toggle="yes">A</italic>, and between the <italic toggle="yes">regulator</italic> and gene <italic toggle="yes">B</italic>. Figure <xref rid="F1" ref-type="fig">1</xref> B shows the corresponding correlation network and Figure <xref rid="F1" ref-type="fig">1D</xref> shows the estimated Pearson correlations, <italic toggle="yes">r</italic>, showing a high correlation between <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> (in red, <italic toggle="yes">r</italic> ∼ 0.91 and <italic toggle="yes">p</italic> &lt; 0.001). This correlation is statistically significant although gene <italic toggle="yes">A</italic> and gene <italic toggle="yes">B</italic> are not directly related – rather, they are only co-regulated by the <italic toggle="yes">regulator</italic>. In contrast, the partial correlation between <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> takes into account the effect of the <italic toggle="yes">regulator</italic>, resulting in a non-significant partial correlation of ρ ∼ 0.02 (Figure <xref rid="F1" ref-type="fig">1C</xref>, using standard partial correlation) and a partial correlation network that does not have an edge between <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> (Figure <xref rid="F1" ref-type="fig">1</xref> C), better reflecting the ground truth (Figure <xref rid="F1" ref-type="fig">1A</xref>). Thus, if the <italic toggle="yes">regulator</italic> is included in the model, it is statistically possible to disentangle direct and indirect linear relationships.</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>Partial correlation versus Pearson’s correlation on artificial data. The left figure shows from top to bottom: (<bold>A</bold>) the ground truth (directed), (<bold>B</bold>) the inferred correlation network (undirected), and (<bold>C</bold>) the inferred partial correlation network (undirected). Direct relationships are shown in black. Pearson’s correlation erroneously infers a relationship between <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic> (figure <bold>B</bold>, red edge). Partial correlation correctly removes this relationship (figure <bold>C</bold>). The right figure (figure <bold>D</bold>) shows the corresponding data as scatterplots (upper half of the matrix) and histograms (diagonal). Corresponding Pearson’s correlation, <italic toggle="yes">r</italic>, and partial correlations, ρ, are given in the lower triangular matrix. Significance levels <italic toggle="yes">P</italic> &lt; 0.001 are marked by three asterisks.</p>
        </caption>
        <graphic xlink:href="gkac1157fig1" position="float"/>
      </fig>
      <p>In this section, we systematically analyze potential issues in estimating partial correlations between variables of different omics layers, and compare how different methods, including DRAGON, are affected by these issues. In our simulations, we considered both high-dimensional settings (many molecular variables) as well as models in which there are different probabilities for direct relationships among variables within and between different omics layers. Table <xref rid="tbl1" ref-type="table">1</xref> describes the simulation study design in detail.</p>
      <table-wrap position="float" id="tbl1">
        <label>Table 1.</label>
        <caption>
          <p>Edge densities and edge numbers for simulation studies <italic toggle="yes">A</italic>, <italic toggle="yes">B</italic>, <italic toggle="yes">C</italic> and <italic toggle="yes">D</italic></p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1">(<italic toggle="yes">k</italic>, <italic toggle="yes">l</italic>)</th>
              <th colspan="2" align="center" rowspan="1">(1,1)</th>
              <th colspan="2" align="center" rowspan="1">(1,2)</th>
              <th colspan="2" align="center" rowspan="1">(2,2)</th>
            </tr>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1">η</th>
              <th rowspan="1" colspan="1">Edges</th>
              <th rowspan="1" colspan="1">η</th>
              <th rowspan="1" colspan="1">Edges</th>
              <th rowspan="1" colspan="1">η</th>
              <th rowspan="1" colspan="1">Edges</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">
                <italic toggle="yes">A</italic>
              </td>
              <td align="center" rowspan="1" colspan="1">0.05</td>
              <td rowspan="1" colspan="1">248</td>
              <td align="center" rowspan="1" colspan="1">0.05</td>
              <td rowspan="1" colspan="1">2500</td>
              <td align="center" rowspan="1" colspan="1">0.05</td>
              <td rowspan="1" colspan="1">6238</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <italic toggle="yes">B</italic>
              </td>
              <td align="center" rowspan="1" colspan="1">0.05</td>
              <td rowspan="1" colspan="1">248</td>
              <td align="center" rowspan="1" colspan="1">0.05</td>
              <td rowspan="1" colspan="1">2500</td>
              <td align="center" rowspan="1" colspan="1">0.005</td>
              <td rowspan="1" colspan="1">624</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <italic toggle="yes">C</italic>
              </td>
              <td align="center" rowspan="1" colspan="1">0.05</td>
              <td rowspan="1" colspan="1">248</td>
              <td align="center" rowspan="1" colspan="1">0.005</td>
              <td rowspan="1" colspan="1">250</td>
              <td align="center" rowspan="1" colspan="1">0.005</td>
              <td rowspan="1" colspan="1">624</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">
                <italic toggle="yes">D</italic>
              </td>
              <td align="center" rowspan="1" colspan="1">0.101</td>
              <td rowspan="1" colspan="1">500</td>
              <td align="center" rowspan="1" colspan="1">0.01</td>
              <td rowspan="1" colspan="1">500</td>
              <td align="center" rowspan="1" colspan="1">0.004</td>
              <td rowspan="1" colspan="1">500</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>We performed four simulation studies, <italic toggle="yes">A</italic> to <italic toggle="yes">D</italic>, with fixed numbers of molecular variables, <italic toggle="yes">p</italic><sub>1</sub> = 100 and <italic toggle="yes">p</italic><sub>2</sub> = 500 for omics layers 1 and 2, respectively. Direct relationships can be simulated by appropriate choice of the entries of the precision matrices <inline-formula><tex-math id="M00045" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\Theta }^{(k,l)}$\end{document}</tex-math></inline-formula> which parameterize the multivariate Gaussian distribution. Different simulation runs correspond to different precision matrices, which were randomly generated as follows:</p>
      <list list-type="order">
        <list-item>
          <p>start with a <italic toggle="yes">p</italic>-dimensional identity matrix, where <italic toggle="yes">p</italic> = <italic toggle="yes">p</italic><sub>1</sub> + <italic toggle="yes">p</italic><sub>2</sub>,</p>
        </list-item>
        <list-item>
          <p>randomly replace a proportion η<sup>(<italic toggle="yes">k</italic>, <italic toggle="yes">l</italic>)</sup> of zeros by values drawn from a uniform distribution ranging from −1 to 1,</p>
        </list-item>
        <list-item>
          <p>replace the diagonal entries <inline-formula><tex-math id="M00046" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\theta_{ii}$\end{document}</tex-math></inline-formula> by <inline-formula><tex-math id="M00047" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\sum_j|\theta_{ij}|$\end{document}</tex-math></inline-formula> plus a small positive value (ε = 0.0001),</p>
        </list-item>
        <list-item>
          <p>normalize the entries <inline-formula><tex-math id="M00048" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\theta_{ij}$\end{document}</tex-math></inline-formula> of the precision matrix by <inline-formula><tex-math id="M00049" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\sqrt{\theta _{ii}\theta _{jj}}$\end{document}</tex-math></inline-formula>.</p>
        </list-item>
      </list>
      <p>Each precision matrix was used to sample from a multivariate normal with mean vector μ = 0 and covariance <inline-formula><tex-math id="M00050" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${\Theta }^{-1}$\end{document}</tex-math></inline-formula>. Finally, we added a noise ε ∼ <italic toggle="yes">N</italic>(μ = 0, σ = 0.1) to each entry of the data matrix.</p>
      <sec id="SEC3-1-1">
        <title>DRAGON adapts to the data by dynamically chosen penalty parameters and improves model inference</title>
        <p>DRAGON uses an analytical estimate of the minimum of <italic toggle="yes">R</italic>, Equation (<xref rid="M6" ref-type="disp-formula">6</xref>). Here, we show that this estimate dynamically adapts to sample and feature size, and to edge densities η<sup>(<italic toggle="yes">k</italic>, <italic toggle="yes">l</italic>)</sup> across a broad range of simulation settings.</p>
        <sec id="SEC3-1-1-1">
          <title>Parameter recovery in Simulation A</title>
          <p>In simulation study <italic toggle="yes">A</italic>, the two omics layers have equal edge densities η<sup>(1, 1)</sup> = η<sup>(1, 2)</sup> = η<sup>(2, 2)</sup> = 0.05. Figure <xref rid="F2" ref-type="fig">2A</xref> and <xref rid="F2" ref-type="fig">C</xref> shows <italic toggle="yes">R</italic> in dependency of λ<sub>1</sub> and λ<sub>2</sub> for the analytical estimate and the ground truth, respectively, for a fixed sample size of <italic toggle="yes">n</italic> = 5000. We observed that estimate and ground truth agree remarkably well, and that they provide almost identical estimates for the position of the minimum of the selected penalty parameters, <inline-formula><tex-math id="M00051" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$(\hat{\lambda }_1,\hat{\lambda }_2)$\end{document}</tex-math></inline-formula>. The GGM estimated according to Equation (<xref rid="M2" ref-type="disp-formula">2</xref>) using the appended data <italic toggle="yes">X</italic> = [<italic toggle="yes">X</italic><sup>(1)</sup>, <italic toggle="yes">X</italic><sup>(2)</sup>] corresponds to the diagonal red lines, such that the two data layers are treated as they would belong to one layer and a single regularization parameter <inline-formula><tex-math id="M00052" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\hat\lambda_1 = \hat\lambda_2 = \hat\lambda$\end{document}</tex-math></inline-formula> is estimated. We observed that DRAGON correctly estimated <inline-formula><tex-math id="M00053" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$(\hat{\lambda }_1,\hat{\lambda }_2)$\end{document}</tex-math></inline-formula> to be near to the diagonal for this simulation study. Supplementary Figures S1 and S2 confirm this finding for lower sample sizes, <italic toggle="yes">n</italic> = 500 and <italic toggle="yes">n</italic> = 1000, respectively.</p>
          <fig position="float" id="F2">
            <label>Figure 2.</label>
            <caption>
              <p>Parameter landscapes for DRAGON. Estimated and true <italic toggle="yes">R</italic> (upper and lower row) in dependency of λ<sub>1</sub> and λ<sub>2</sub> in simulation studies <italic toggle="yes">A</italic> (left column) and <italic toggle="yes">B</italic> (right column). Figures <bold>A</bold> and <bold>B</bold> show the estimated <italic toggle="yes">R</italic> for study <italic toggle="yes">A</italic> and <italic toggle="yes">B</italic>, respectively. Figure <bold>C</bold> and D show the corresponding ground truth. The red circles indicate the minima for each plot in the λ<sub>1</sub>–λ<sub>2</sub> plane, and the green triangles give the minima on the diagonal <italic toggle="yes">R</italic> values shown in red, corresponding to the standard GGM.</p>
            </caption>
            <graphic xlink:href="gkac1157fig2" position="float"/>
          </fig>
        </sec>
        <sec id="SEC3-1-1-2">
          <title>Parameter recovery in simulation B</title>
          <p>In Simulation B, we investigated the influence of the edge densities η<sup>(<italic toggle="yes">k</italic>, <italic toggle="yes">l</italic>)</sup> on <italic toggle="yes">R</italic>. For this, we reduced the edge density η<sup>(2, 2)</sup> to η<sup>(2, 2)</sup> = 0.005. Again, we observed a remarkable agreement between estimated and true <italic toggle="yes">R</italic>, shown in Figure <xref rid="F2" ref-type="fig">2B</xref> and <xref rid="F2" ref-type="fig">D</xref>, respectively, which is also the case for the estimated minima <inline-formula><tex-math id="M00054" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$(\hat{\lambda }_1,\hat{\lambda }_2)$\end{document}</tex-math></inline-formula>. Note, <inline-formula><tex-math id="M00055" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\hat{\lambda }_1$\end{document}</tex-math></inline-formula> now strongly differs from <inline-formula><tex-math id="M00056" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\hat{\lambda }_2$\end{document}</tex-math></inline-formula>. Since <inline-formula><tex-math id="M00057" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\lambda_2 &gt;\lambda_1$\end{document}</tex-math></inline-formula>, the second omics data layer is stronger penalized than the first.</p>
        </sec>
        <sec id="SEC3-1-1-3">
          <title>Parameter recovery in simulations C and D</title>
          <p>We repeated this analysis for two further simulation studies, <italic toggle="yes">C</italic> and <italic toggle="yes">D</italic>, both of which have unbalanced edge densities with results shown in Supplementary Figures S3, S4, and S5 for <italic toggle="yes">n</italic> = 500, <italic toggle="yes">n</italic> = 1000, and <italic toggle="yes">n</italic> = 5000, respectively. Here, we also found that DRAGON correctly estimates <italic toggle="yes">R</italic> and that λ<sub>1</sub> and λ<sub>2</sub> are chosen by the algorithm accordingly to minimize <italic toggle="yes">R</italic>.</p>
        </sec>
        <sec id="SEC3-1-1-4">
          <title>Model inference in simulations A–D</title>
          <p>We next analyzed how the DRAGON regularization scheme, which augments covariance shrinkage by omics layer-specific regularization parameters, affects model inference. We repeated simulation studies <italic toggle="yes">A</italic> to <italic toggle="yes">D</italic> 20 times for different sample sizes <italic toggle="yes">n</italic> and evaluated the log-likelihood on <italic toggle="yes">n</italic> = 1000 test samples (Supplementary Figure S6). While we recognize that few omics studies have 1000 or more samples, single-cell experiments generally assay thousands of cells and large cohort studies are beginning to develop omics databases that include populations of this size or larger.</p>
          <p>We found similar results on an absolute scale (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figures S6a–d</xref>). However, results were clearly in favor of DRAGON when we evaluated the log-likelihood difference (Supplementary Figures S6e–h). This measure has the advantage that it removes variability due to different simulation runs. The green line corresponds to the median log-likelihood difference and the error bands to the <inline-formula><tex-math id="M00058" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$25\%$\end{document}</tex-math></inline-formula> and <inline-formula><tex-math id="M00059" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$75\%$\end{document}</tex-math></inline-formula> percentiles. Results were slightly in favor of the GGM for the balanced study <italic toggle="yes">A</italic>, but in simuations <italic toggle="yes">B</italic>, <italic toggle="yes">C</italic>, and <italic toggle="yes">D</italic>, DRAGON outperformed the standard GGM as indicated by positive values for the difference. The greatest improvements were seen for the unbalanced simulation <italic toggle="yes">B</italic>. We can also see that as the sample size <italic toggle="yes">n</italic> increases with the number of predictors <italic toggle="yes">p</italic> remaining fixed, DRAGON and GGM estimates coincide, as demonstrated by a vanishing log-likelihood difference.</p>
        </sec>
      </sec>
      <sec id="SEC3-1-2">
        <title>DRAGON outperforms the state of the art with respect to edge recovery</title>
        <p>Adjusted <italic toggle="yes">p</italic>-values (<italic toggle="yes">q</italic>-values) were assigned as described in the Materials and Methods section and were used to assess the edge-recovery performance in simulations <italic toggle="yes">A</italic> to <italic toggle="yes">D</italic> using receiver operating characteristic (ROC) curves for DRAGON, GGM, GeneNet, B-NW-SL, D-S-NW-SL and D-S-GL. Variables were standardized for performance comparisons.</p>
        <p>We first compared the results of DRAGON and GGM inference methods. Figure <xref rid="F3" ref-type="fig">3A</xref> shows how the area under the ROC curve (AUC) depends on the number of training samples <italic toggle="yes">n</italic> for simulation study <italic toggle="yes">A</italic>. We saw almost identical performance for DRAGON (blue) and GGM (red) for all sample sizes in our simulation, a result consistent with our previous findings. For simulation studies <italic toggle="yes">B</italic>, <italic toggle="yes">C</italic> and <italic toggle="yes">D</italic>, the corresponding results are shown in Figure <xref rid="F3" ref-type="fig">3B</xref>–<xref rid="F3" ref-type="fig">D</xref> and illustrate substantial improvements for DRAGON compared to GGM. For example, in simulation study <italic toggle="yes">B</italic>, DRAGON achieved an AUC for <italic toggle="yes">n</italic> ≈ 250 samples that is compatible to that of the GGM for <italic toggle="yes">n</italic> ≈ 1000 samples. This improved performance of DRAGON is further illustrated by Figure <xref rid="F4" ref-type="fig">4</xref> A to D that shows the respective AUC differences; we found AUC improvements up to ∼0.13 (study <italic toggle="yes">B</italic>), ∼0.05 (study <italic toggle="yes">C</italic>) and ∼0.11 (study <italic toggle="yes">D</italic>). In the balanced simulation scenario <italic toggle="yes">A</italic> where we expect the GGM and DRAGON to have similar performance, the GGM negligibly outperformed DRAGON, as shown by small negative values in Figure <xref rid="F4" ref-type="fig">4A</xref>. As an alternative performance assessment, we used the average area under the precision-recall curve (AUC-PR) (Supplementary Figure S7). These results also show the performance advantages of DRAGON compared to GGM with AUC-PR differences up to ∼0.07, ∼0.03, ∼0.08, for studies <italic toggle="yes">B</italic> to <italic toggle="yes">D</italic>, respectively.</p>
        <fig position="float" id="F3">
          <label>Figure 3.</label>
          <caption>
            <p>Area under the ROC curve (AUC) for edge-recovery performance versus sample size <italic toggle="yes">n</italic> of simulation studies <italic toggle="yes">A</italic> to <italic toggle="yes">D</italic> (columns). Each row compares DRAGON (blue) with GGM (red, <bold>A–D</bold>), GeneNet (magenta, <bold>E–H</bold>), B-NW-SL (purple, <bold>I–L</bold>), D-S-NW-SL (cyan, <bold>M–P</bold>) and D-S-GL (orange, <bold>Q–T</bold>), respectively. The lines correspond to the median AUC and the bands to the <inline-formula><tex-math id="M00060" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$25\%$\end{document}</tex-math></inline-formula> and <inline-formula><tex-math id="M00061" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$75\%$\end{document}</tex-math></inline-formula> percentiles of the distribution.</p>
          </caption>
          <graphic xlink:href="gkac1157fig3" position="float"/>
        </fig>
        <fig position="float" id="F4">
          <label>Figure 4.</label>
          <caption>
            <p>Area under the ROC curve (AUC) differences versus sample size <italic toggle="yes">n</italic> of simulation studies <italic toggle="yes">A</italic> to <italic toggle="yes">D</italic> (columns). Each row corresponds to the AUC difference DRAGON minus GGM (<bold>A–D</bold>), DRAGON minus GeneNet (Figure <bold>E</bold>–<bold>H</bold>), DRAGON minus B-NW-SL (<bold>I–L</bold>), DRAGON minus D-S-NW-SL (<bold>M–P</bold>), and DRAGON minus D-S-GL (<bold>Q–T</bold>), respectively. The green lines correspond to the median AUC and the bands to the <inline-formula><tex-math id="M00062" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$25\%$\end{document}</tex-math></inline-formula> and <inline-formula><tex-math id="M00063" notation="LaTeX">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$75\%$\end{document}</tex-math></inline-formula> percentiles of the distribution.</p>
          </caption>
          <graphic xlink:href="gkac1157fig4" position="float"/>
        </fig>
        <p>Analogous AUC analyses were performed comparing DRAGON with GeneNet, B-NW-SL, D-S-NW-SL and D-S-GL with results shown in Figures <xref rid="F3" ref-type="fig">3E</xref>–<xref rid="F3" ref-type="fig">T</xref> and <xref rid="F4" ref-type="fig">4E</xref>–<xref rid="F4" ref-type="fig">T</xref>. Corresponding AUC-PR curves and AUC-PR differences are shown in Supplementary Figures S7 and S8, respectively. For both AUC and AUC-PR, we found in simulated data sets <italic toggle="yes">A</italic>, <italic toggle="yes">B</italic> and <italic toggle="yes">D</italic> that DRAGON’s improved estimates are of the same size (for GeneNet and B-NW-SL) or substantially larger (for D-S-NW-SL and D-S-GL) than we found in comparing DRAGON to GGM. In simulation study <italic toggle="yes">C</italic>, we found comparable performance of GeneNet and DRAGON across a large range of sample sizes (Figures <xref rid="F3" ref-type="fig">3G</xref> and <xref rid="F4" ref-type="fig">4G</xref>) but that GeneNet produced an inflated FDR (Supplementary Figure S9g). FDRs and FDR differences for all methods are summarized in Supplementary Figures S9 and S10. Table <xref rid="tbl2" ref-type="table">2</xref> summarizes the minimum number of samples <italic toggle="yes">n</italic> (as well as upper bounds on <italic toggle="yes">p</italic>/<italic toggle="yes">n</italic>) for each of the simulation studies required to reach network confidence levels AUC &gt;0.8. As can be seen, DRAGON reached confidence for substantially smaller <italic toggle="yes">n</italic> and larger <italic toggle="yes">p</italic>/<italic toggle="yes">n</italic> ratios than the other methods.</p>
        <table-wrap position="float" id="tbl2">
          <label>Table 2.</label>
          <caption>
            <p>Lower bounds on <italic toggle="yes">n</italic> and upper bounds on <italic toggle="yes">p</italic>/<italic toggle="yes">n</italic> necessary to achieve confidence in edge recovery defined via a median AUC&gt;0.8 in simulation studies <italic toggle="yes">A</italic>, <italic toggle="yes">B</italic>, <italic toggle="yes">C</italic> and <italic toggle="yes">D</italic>. Best performance is indicated in boldface letters. The evaluated sample sizes were <italic toggle="yes">n</italic> ∈ {2<sup>6</sup>, ⌊2<sup>6.5</sup>⌋, 2<sup>7</sup>, …, ⌊2<sup>13.5</sup>⌋, 2<sup>14</sup>}</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th rowspan="1" colspan="1">Simulation</th>
                <th colspan="2" align="center" rowspan="1">
                  <italic toggle="yes">A</italic>
                </th>
                <th colspan="2" align="center" rowspan="1">
                  <italic toggle="yes">B</italic>
                </th>
                <th colspan="2" align="center" rowspan="1">
                  <italic toggle="yes">C</italic>
                </th>
                <th colspan="2" align="center" rowspan="1">
                  <italic toggle="yes">D</italic>
                </th>
              </tr>
              <tr>
                <th rowspan="1" colspan="1"/>
                <th rowspan="1" colspan="1">
                  <italic toggle="yes">n</italic>
                </th>
                <th rowspan="1" colspan="1"><italic toggle="yes">p</italic>/<italic toggle="yes">n</italic></th>
                <th rowspan="1" colspan="1">
                  <italic toggle="yes">n</italic>
                </th>
                <th rowspan="1" colspan="1"><italic toggle="yes">p</italic>/<italic toggle="yes">n</italic></th>
                <th rowspan="1" colspan="1">
                  <italic toggle="yes">n</italic>
                </th>
                <th rowspan="1" colspan="1"><italic toggle="yes">p</italic>/<italic toggle="yes">n</italic></th>
                <th rowspan="1" colspan="1">
                  <italic toggle="yes">n</italic>
                </th>
                <th rowspan="1" colspan="1"><italic toggle="yes">p</italic>/<italic toggle="yes">n</italic></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">DRAGON</td>
                <td rowspan="1" colspan="1">4096</td>
                <td rowspan="1" colspan="1">0.15</td>
                <td rowspan="1" colspan="1">
                  <bold>362</bold>
                </td>
                <td rowspan="1" colspan="1">
                  <bold>1.66</bold>
                </td>
                <td rowspan="1" colspan="1">
                  <bold>128</bold>
                </td>
                <td rowspan="1" colspan="1">
                  <bold>4.69</bold>
                </td>
                <td rowspan="1" colspan="1">
                  <bold>181</bold>
                </td>
                <td rowspan="1" colspan="1">
                  <bold>3.31</bold>
                </td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">GGM</td>
                <td rowspan="1" colspan="1">4096</td>
                <td rowspan="1" colspan="1">0.15</td>
                <td rowspan="1" colspan="1">1448</td>
                <td rowspan="1" colspan="1">0.41</td>
                <td rowspan="1" colspan="1">181</td>
                <td rowspan="1" colspan="1">3.31</td>
                <td rowspan="1" colspan="1">512</td>
                <td rowspan="1" colspan="1">1.17</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">GeneNet</td>
                <td rowspan="1" colspan="1">4096</td>
                <td rowspan="1" colspan="1">0.15</td>
                <td rowspan="1" colspan="1">1448</td>
                <td rowspan="1" colspan="1">0.41</td>
                <td rowspan="1" colspan="1">181</td>
                <td rowspan="1" colspan="1">3.31</td>
                <td rowspan="1" colspan="1">512</td>
                <td rowspan="1" colspan="1">1.17</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">B-NW-SL</td>
                <td rowspan="1" colspan="1">4096</td>
                <td rowspan="1" colspan="1">0.15</td>
                <td rowspan="1" colspan="1">1448</td>
                <td rowspan="1" colspan="1">0.41</td>
                <td rowspan="1" colspan="1">181</td>
                <td rowspan="1" colspan="1">3.31</td>
                <td rowspan="1" colspan="1">512</td>
                <td rowspan="1" colspan="1">1.17</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">D-S-NW-SL</td>
                <td rowspan="1" colspan="1">4096</td>
                <td rowspan="1" colspan="1">0.15</td>
                <td rowspan="1" colspan="1">1448</td>
                <td rowspan="1" colspan="1">0.41</td>
                <td rowspan="1" colspan="1">512</td>
                <td rowspan="1" colspan="1">1.17</td>
                <td rowspan="1" colspan="1">1024</td>
                <td rowspan="1" colspan="1">0.59</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">D-S-GL</td>
                <td rowspan="1" colspan="1">4096</td>
                <td rowspan="1" colspan="1">0.15</td>
                <td rowspan="1" colspan="1">2048</td>
                <td rowspan="1" colspan="1">0.29</td>
                <td rowspan="1" colspan="1">724</td>
                <td rowspan="1" colspan="1">0.83</td>
                <td rowspan="1" colspan="1">1448</td>
                <td rowspan="1" colspan="1">0.41</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>We also verified that DRAGON correctly estimates <italic toggle="yes">P</italic>-values and false discovery rates (FDRs). First, we performed simulations under the null hypothesis of no partial correlation (ρ = 0) and verified that the <italic toggle="yes">P</italic>-value distributions are flat for different sets of the regularization parameters λ<sub>1</sub> and λ<sub>2</sub> (Supplementary Figures S12 and S13). The simulated data sets were motivated as follows: we recorded the λ<sub>1</sub> and λ<sub>2</sub> values for each simulation run in study <italic toggle="yes">A</italic> to <italic toggle="yes">D</italic>, which yielded the results shown in Supplementary Figure S12. We extracted the corresponding parameter sets at <italic toggle="yes">n</italic> = 256, <italic toggle="yes">n</italic> = 1024 and <italic toggle="yes">n</italic> = 4096 samples, which correspond respectively to a highly regularized estimate, a moderately regularized one, and one with low regularization. This resulted, in total, in 12 pairs (λ<sub>1</sub>, λ<sub>2</sub>) with the associated <italic toggle="yes">P</italic>-value distributions under the null hypothesis that are shown in Supplementary Figure S13; as desired, these distributions are flat. Further, we recorded the FDRs corresponding to studies <italic toggle="yes">A</italic> to <italic toggle="yes">D</italic> (Supplementary Figures S9a to d and S11) for the empirical estimate of κ and the theoretical value κ = <italic toggle="yes">n</italic> − 1 − (<italic toggle="yes">p</italic> − 2), respectively. As expected, the observed FDR for DRAGON approaches 0.05 as the sample size increases. Analogous plots for the comparison methods can be found in Supplementary Figure S9e–t. DRAGON generally outperforms the other methods, some of which show inflated FDRs indicating an overly liberal method (GeneNet) or deflated FDRs indicating an overly conservative method (D-S-NW-SL and D-S-GL).</p>
      </sec>
    </sec>
    <sec id="SEC3-2">
      <title>Integrative DRAGON analysis of transcriptome and methylome in TCGA breast cancer specimens</title>
      <p>Epigenetic aberrations such as DNA methylation are associated with altered patterns of gene regulation during the development and progression of complex diseases such as cancer (<xref rid="B28" ref-type="bibr">28</xref>). Given the performance advantages of DRAGON over other partial correlation methods, here we present an illustrative application of DRAGON to integrate promoter methylation and gene expression data in 765 breast cancer specimens from The Cancer Genome Atlas (TCGA) (<xref rid="B29" ref-type="bibr">29</xref>). We began with a list of 1639 human transcription factors (TFs) (<xref rid="B30" ref-type="bibr">30</xref>), of which 1557 had annotated promoter methylation data meeting quality control measures in TCGA, 1311 had gene expression data, and 1280 had both. Below, we outline the analysis of these data; further details regarding the sample population, data preprocessing, model inference, community detection and Reactome pathway enrichment analysis are summarized in Supplementary Sections 4–8, where a summary of baseline characteristics is given in Suppl. Table S1, the distribution of promoter methylation is shown in Supplementary Figure S14, and the distribution of methylation in relation to CpG islands is shown in Supplementary Figure S15.</p>
      <sec id="SEC3-2-1">
        <title>Data acquisition, processing and estimated DRAGON model</title>
        <p>The GenomicDataCommons (<xref rid="B31" ref-type="bibr">31</xref>) R package, version 1.20.1, was used to download TCGA breast cancer data (Project ID TCGA-BRCA; dbGaP Study Accession phs000178) from the Genomic Data Commons. Methylation levels from the Illumina 450k array were processed from raw data into beta values with the TCGA Methylation Array Harmonization Workflow (<ext-link xlink:href="https://docs.gdc.cancer.gov/Data/Bioinformatics_Pipelines/Methylation_Pipeline/" ext-link-type="uri">https://docs.gdc.cancer.gov/Data/Bioinformatics_Pipelines/Methylation_Pipeline/</ext-link>, Accessed: 2022-05-25), which uses SeSAMe (<xref rid="B32" ref-type="bibr">32</xref>) for signal detection and quality control. Methylation was summarized at the gene level by averaging beta values for probes in the promoter region of each gene of interest and methylation data were transformed to approximate normality with the nonparanormal transformation (<xref rid="B33" ref-type="bibr">33</xref>). RNA-seq data were processed according to the TCGA RNA-Seq Alignment Workflow (<ext-link xlink:href="https://docs.gdc.cancer.gov/Data/Bioinformatics_Pipelines/Expression_mRNA_Pipeline/" ext-link-type="uri">https://docs.gdc.cancer.gov/Data/Bioinformatics_Pipelines/Expression_mRNA_Pipeline/</ext-link>, Accessed: 2022-05-25) to produce gene expression levels; this pipeline uses the Spliced Transcripts Alignment to a Reference (STAR) (<xref rid="B34" ref-type="bibr">34</xref>) algorithm to align reads and generate counts which were reported as transcripts per million (TPM), among other measures.</p>
        <p>Methylation and expression data for the transcription factors for this breast cancer data set were loaded into DRAGON and a partial correlation network was calculated. A thresholded version of the DRAGON-estimated network consisting of all edges with FDR &lt;0.005 and all nodes with degree &gt;0 is shown in Figure <xref rid="F5" ref-type="fig">5</xref>. The network contains 3631 edges on 2106 nodes. 1168 of the nodes represent methylation (75% of the methylation variables) and 938 represent gene expression (72% of the gene expression variables).</p>
        <fig position="float" id="F5">
          <label>Figure 5.</label>
          <caption>
            <p>DRAGON multiomic network on TCGA methylation and gene expression data from 765 women with breast cancer.</p>
          </caption>
          <graphic xlink:href="gkac1157fig5" position="float"/>
        </fig>
      </sec>
      <sec id="SEC3-2-2">
        <title>DRAGON discovers meaningful promoter methylation-gene expression relationships</title>
        <p>DNA methylation can regulate gene expression by blocking TF binding or by altering the binding of other regulatory proteins (<xref rid="B35" ref-type="bibr">35</xref>). In cancer, hypermethylation of tumor suppressor gene promoters can lead to their inactivation by blocking transcription factors and inhibiting the recruitment of the transcriptional machinery (<xref rid="B36" ref-type="bibr">36</xref>). On the other hand, DNA methylation results from the actions of proteins (methylases and demethylases) whose levels in turn result from changes in the expression of genes encoding these proteins. DRAGON provides a means to study both changes in gene expression resulting from methylation and the activation of methylation through changes in gene expression.</p>
        <p>Because of the complex, correlated nature of methylation and gene expression, a multi-omic correlation network based on these data may be too noisy to identify meaningful methylation-expression relationships. To illustrate this, we created a Pearson correlation network on the methylation-gene expression data with 824,599 significant methylation-gene expression edges based on the criteria FDR &lt;0.05. Notably, of these edges, only 861 (0.1%) were edges between the expression of a gene and the methylation of its promoter – the associations we expect functionally to be the most significant (175 (20%) positive and 686 (80%) negative edges). In contrast, when using DRAGON to estimate the partial correlation network on the same data, the result was a much sparser network consisting of 769 significant methylation-gene expression edges (FDR &lt;0.05). Of these edges, 333 (43%) were associations between expression of a gene and methylation of its promoter (26 (8%) positive and 307 (92%) negative partial correlations). The high proportion of negative partial correlations is an important ‘sanity check’ on the performance of DRAGON, as promoter methylation suppresses transcription for most genes (<xref rid="B36" ref-type="bibr">36</xref>). To further illustrate the discriminatory power of partial correlations relative to simple correlations, we examined the 769 most significant Pearson correlation edges between gene expression and methylation sites (corresponding to the number of gene expression-methylation edges in the DRAGON network) and found only 33 (4%) to be associations between expression of a gene and methylation of its promoter. Note that neither the Pearson correlation-based analysis nor the DRAGON analysis use any prior knowledge about methylation site - gene correspondence.</p>
        <p>Returning to the DRAGON network, we ranked gene expression nodes according to the number of significant edges to methylation nodes they possessed (Table <xref rid="tbl3" ref-type="table">3</xref>). The top-ranking gene, with 12 edges to methylation nodes (7 positive and 5 negative partial correlations), was ZFP57 (Figure <xref rid="F6" ref-type="fig">6</xref>) which is a zinc finger transcription factor containing a KRAB domain and which may play a negative regulatory role (<xref rid="B37" ref-type="bibr">37</xref>). The strongest gene expression - promoter methylation edge was observed between ZFP57 and methylation of its own promoter (FDR &lt; 10<sup>−100</sup>, ρ = −0.25), followed by methylation of the SKOR2 promoter (FDR &lt; 10<sup>−3</sup>, ρ = −0.06), and methylation of the ZNF121 promoter (FDR &lt; 10<sup>−3</sup>, ρ = 0.06). A comprehensive list of edges is shown in Table <xref rid="tbl3" ref-type="table">3</xref>. ZFP57 is known to contribute in maintaining the methylation memory of parental origin (<xref rid="B38" ref-type="bibr">38</xref>). It controls DNA methylation during the earliest multicellular developmental stages at multiple imprinting control regions (<xref rid="B39" ref-type="bibr">39</xref>,<xref rid="B40" ref-type="bibr">40</xref>), which is in line with its multiple related methylation sites suggested by DRAGON. Most importantly, ZFP57 has been shown to suppress proliferation of breast cancer cells through down-regulation of the MEST-mediated Wnt/β-catenin signalling pathway (<xref rid="B41" ref-type="bibr">41</xref>).</p>
        <table-wrap position="float" id="tbl3">
          <label>Table 3.</label>
          <caption>
            <p>Summary of the 4 gene-expression variables with most edges to methylation variables ordered by rank. Methylation variables (last column) are ordered by partial correlations (from high to low absolute values), where the +/− signs in brackets give the signs of the estimated partial correlations</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th rowspan="1" colspan="1">rank</th>
                <th rowspan="1" colspan="1">TF RNA</th>
                <th rowspan="1" colspan="1"># GE-methyl. edges</th>
                <th align="center" rowspan="1" colspan="1">Methylation variables</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">1</td>
                <td rowspan="1" colspan="1">ZFP57</td>
                <td rowspan="1" colspan="1">12</td>
                <td rowspan="1" colspan="1">ZFP57(−), SKOR2(−), ZNF121(+), IRF6(+), RHOXF1(+), MNX1(−), VAX2(−),</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1">ZNF821(+), ZNF181(+), ZNF559(−), ZNF521(+), ZNF853(+)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">2</td>
                <td rowspan="1" colspan="1">ZNF334</td>
                <td rowspan="1" colspan="1">11</td>
                <td rowspan="1" colspan="1">ZNF334(−), ZNF266(−), KLF2(−), ZKSCAN4(−), HOXC8(+), ZNF746(−),</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1">HOXC9(−), ZFP1(+), ZNF728(+), ZSCAN25(−), NPAS1(+)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">3</td>
                <td rowspan="1" colspan="1">NR6A1</td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">FOXO6(+), IKZF3(+), JRK(−), NR5A1(+), NFIC(+), ZNF654(−), FOXR1(−),</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1">ETV2(+), ELK3(+), FOXP1(−)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">4</td>
                <td rowspan="1" colspan="1">MYRFL</td>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">MYRFL(−), ZFP69B(−), AHR(−), HOXB7(+), ZNF467(−), THAP12(+), ZNF251(−), MTF1(+), ARID5A(+), RORB(+)</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <fig position="float" id="F6">
          <label>Figure 6.</label>
          <caption>
            <p>Neighborhoods of ZFP57 and ZNF334, two of the transcription factor gene expression nodes that serve as hubs in the DRAGON breast cancer network. Turquoise nodes represent gene expression and orange nodes represent promoter methylation. Red edges indicate positive partial correlations; blue, negative. Edge width is proportional to the strength of partial correlation. Larger nodes indicate higher node degrees. Edges with FDR &lt;0.05 are shown.</p>
          </caption>
          <graphic xlink:href="gkac1157fig6" position="float"/>
        </fig>
        <p>The second TF was ZNF334, another zinc finger protein transcription factor, which had 11 edges to methylation variables (4 positive, 7 negative; Figure <xref rid="F6" ref-type="fig">6</xref>). Again, the strongest edge was observed to its own methylation site (FDR &lt;10<sup>−34</sup>, ρ = −0.175), followed by ZNF266 (FDR =3.6 × 10<sup>−4</sup>, ρ = −0.058) and KLF2 (FDR =7.6 × 10<sup>−4</sup>, ρ = −0.056). ZNF334 was recently identified as tumor suppressor of triple-negative breast cancer and higher ZNF334 expression was shown to be associated with better survival outcomes (<xref rid="B42" ref-type="bibr">42</xref>). DRAGON suggests that this suppression may be due to hypermethylation of its promoter region. A similar pattern has been observed in some other cancers, including hepatocellular carcinoma (<xref rid="B43" ref-type="bibr">43</xref>).</p>
        <p>The third and fourth top hits were the transcription factors NR6A1 (also known as GCNF) and MYRFL, both showing 10 edges to methylation variables (Supplementary Figure S16). Unlike the other transcription factors we identified, NR6A1 was not related to its own methylation site (FDR ∼1, ρ ∼ 0). Its strongest methylation-gene expression edges were observed to methylation sites attributed to the genes FOXO6 (FDR &lt;1 × 10<sup>−4</sup>, ρ = 0.061) and IKZF3 (FDR &lt;1 × 10<sup>−4</sup>, ρ = 0.061). FOXO6 is a transcription factor known to play multiple roles in breast cancer. Its downregulation is implicated in promotion of the epithelial–mesenchymal transition, in migration and proliferation of breast cancer cells, and in reduced cell resistance to the anti-cancer drug paclitaxel through the PI3K/Akt signaling pathway (<xref rid="B44" ref-type="bibr">44</xref>,<xref rid="B45" ref-type="bibr">45</xref>). IKZF3 is a member of the Ikaros family of zinc-finger proteins that has been shown to work with other transcription factors to regulate immune response in breast cancer (<xref rid="B46" ref-type="bibr">46</xref>) and its knockdown has been shown to dramatically increase breast cancer response to chimeric antigen receptor T-cell (CAR-T) therapy (<xref rid="B47" ref-type="bibr">47</xref>).</p>
        <p>In <italic toggle="yes">mus musculus</italic>, NR6A1 has been shown to interact with DNMT3B (DNA (cytosine-5)-methyltransferase 3B) to induce promoter methylation of the genes Oct-3/4 (<xref rid="B48" ref-type="bibr">48</xref>). DNMT3B together with DNMT3A is essential for the <italic toggle="yes">de novo</italic> methylation in early development (<xref rid="B49" ref-type="bibr">49</xref>). In addition to its role as a transcription factor, NRA61 is an orphan nuclear receptor normally expressed in germ cells of gonads and highly expressed in triple-negative and ER+ HER2– breast cancer and so has been suggested as an ideal drug target (<xref rid="B50" ref-type="bibr">50</xref>). MYRFL follows the more typical pattern, having its strongest methylation-gene expression edge to its own methylation site (FDR &lt;1 × 10<sup>−7</sup>, ρ = −0.073). MYRFL encodes a transcription factor that is required for central nervous system myelination and it has been identified as a member of a regulatory cluster of genes on chromosome 12 that has been associated with elevated risk of breast cancer (<xref rid="B51" ref-type="bibr">51</xref>).</p>
        <p>Although this analysis does not fully account for either the complexities of breast cancer and its subtypes or for the interplay of regulatory mechanisms active in cells and limited exploration to the transcription factors themselves, it already paints a compelling picture of the interplay between epigenetic regulation through altered patterns of methylation in breast cancer and activation or repression of key regulatory proteins that control breast cancer risk, cell proliferation and response to various therapeutic interventions.</p>
      </sec>
      <sec id="SEC3-2-3">
        <title>Community detection and enrichment analysis</title>
        <p>To further analyze the complex structure of the estimated network, we clustered nodes using community detection on the DRAGON-estimated network thresholded at FDR &lt;0.005. This threshold was based on inspection of the distribution of FDR-corrected <italic toggle="yes">p</italic>-values; Supplementary Figure S17. Community detection was performed using the <monospace>cluster_fast_greedy</monospace> algorithm as implemented in the <monospace>igraph</monospace> R package (<xref rid="B52" ref-type="bibr">52</xref>,<xref rid="B53" ref-type="bibr">53</xref>) (see Supplement). Using this algorithm, 169 communities were detected, 59 of which had at least 5 nodes.</p>
        <p>To assess the enrichment of methylation-gene expression communities for functions potentially related to breast cancer, we performed an over-representation analysis (ORA) for Reactome gene sets (<xref rid="B54" ref-type="bibr">54</xref>) within each of the 59 communities with at least 5 nodes (for details of the ORA, see Supplement). The <monospace>fora</monospace> function of the <monospace>fgsea</monospace> R package was used to conduct the ORA (<xref rid="B55" ref-type="bibr">55</xref>). Reactome gene sets with at least 3 genes were considered (<monospace>minSize</monospace> = 3). For the analysis presented here, it should be noted that each transcription factor gene may appear twice, once based on its expression and once based on its methylation. Therefore, the universe of possible genes considered for the ORA (and used to set background expectations) is twice the size of the number of TFs included in the DRAGON model. We also performed an ORA assessing enrichment for methylation only and one assessing enrichment for expression only. A Reactome pathway was identified as over-represented in a community if its FDR was &lt;0.05 in at least one of these three ORAs (Benjamini-Hochberg FDR as implemented in <monospace>fgsea</monospace>). Ten of the 59 communities of size ≥5 genes were enriched for at least one REACTOME pathway at FDR &lt;0.05; complete results of the enrichment analysis are available in <xref rid="sup1" ref-type="supplementary-material">Supplementary Data 1</xref>. Here, we highlight two communities that illustrate DRAGON’s ability to provide unexpected insight into disease processes.</p>
        <p>Community 5 consists of 39 TF nodes, 14 based on TF gene expression and 25 based on TF promoter methylation (Figure <xref rid="F7" ref-type="fig">7</xref>). The TF set in community 5 is enriched for several Reactome pathways related to the TFAP2 family of transcription factors (<xref rid="sup1" ref-type="supplementary-material">Supplementary Data 1</xref>). TFAP2C has been implicated in estrogen response signaling in breast cancer, which plays a major role in breast cancer development, progression, and therapeutic response (<xref rid="B56" ref-type="bibr">56</xref>); estrogen response signaling is also a key determinant of breast cancer molecular subtype (<xref rid="B57" ref-type="bibr">57</xref>).</p>
        <fig position="float" id="F7">
          <label>Figure 7.</label>
          <caption>
            <p>Example communities of interest in the DRAGON breast cancer gene expression-methylation network. Community 5 contains the TFAP2 family of transcription factors. Community 38 contains several hallmark cancer genes that are highly connected.</p>
          </caption>
          <graphic xlink:href="gkac1157fig7" position="float"/>
        </fig>
        <p>To explore the role of the TFAP2 family in our DRAGON network, we obtained mRNA-based subtype classifications (basal, HER2, luminal A, luminal B and normal) for the tumor samples using the <monospace>PanCancerAtlas_subtypes</monospace> function from the <monospace>TCGAbiolinks</monospace> R package (<xref rid="B58" ref-type="bibr">58</xref>). We then evaluated subtype-specific methylation and expression among the TFAP2 genes represented in Community 5 (TFAP2A methylation and expression, TFAP2B methylation and expression, TFAP2C expression; Supplementary Figure S18).</p>
        <p>TFAP2A and TFAP2B methylation both differed significantly based on subtype (Kruskal–Wallis test, TFAP2A <italic toggle="yes">p</italic> = 3.3 × 10<sup>−4</sup>; TFAP2B <italic toggle="yes">p</italic> &lt; 2.2 × 10<sup>−</sup><sup>16</sup>) as did TFAP2A, TFAP2B and TFAP2C expression (TFAP2A <italic toggle="yes">p</italic> = 1.9 × 10<sup>−12</sup>, TFAP2B <italic toggle="yes">p</italic> &lt; 2.2 × 10<sup>−</sup><sup>16</sup>, TFAP2C <italic toggle="yes">p</italic> &lt; 1.9 × 10<sup>−10</sup>). However, TFAP2C methylation, which was notably excluded from this community, did not differ significantly between subtypes (<italic toggle="yes">p</italic> = 0.17). To illustrate the multi-omic phenotyping possible with DRAGON communities, we investigated TFAP2B further. The median TFAP2B promoter methylation beta level was 0.55 in basal samples versus 0.17 in non-basal samples; the median TFAP2B expression among basal samples was 0.49 TPM versus a median of 36.46 TPM in non-basal samples. This multi-omic phenotype of increased methylation and decreased expression in basal samples follows the canonical paradigm that promoter methylation results in gene silencing. To explore the predictive power of this joint information, we constructed a logistic regression model for multi-omic subtype classification, regressing basal vs. non-basal subtype against TFAP2B methylation, expression, and an interaction term between the two. In the resulting model, TFAP2B methylation and the interaction term between TFAP2B methylation and expression were both significant (methylation: OR = 147.76, 95 % CI: [44.21, 493.82]; methylation*expression: OR = 0.873, 95 % CI: [0.797, 0.957]) while TFAP2B expression was not (OR = 1.004, 95 % CI: [0.989, 1.018]). The AUROC of this model was 0.85; in contrast, the AUROC of a similar model using TFAP2B methylation alone as a predictor was 0.82 and using TFAP2B expression alone, 0.79, demonstrating the synergistic power of multi-omic features for class discrimination. Although this classification model does not outperform the expression-based subtype classification used by the TCGA, these results are nonetheless impressive given that they are based on two measurements of the omic state of a single gene.</p>
        <p>Community 38 consists of 40 nodes, six of which represent promoter methylation and 34 of which represent gene expression (Figure <xref rid="F7" ref-type="fig">7</xref>). This community is enriched for 25 Reactome pathways, including signaling by receptor tyrosine kinases (FDR = 6.4 × 10<sup>−9</sup>), estrogen-dependent gene expression (FDR = 1.5 × 10<sup>−3</sup>), PTEN regulation (FDR = 0.02), and MAPK family signaling cascades (FDR = 0.02). The nodes primarily driving these enrichments include EGR1, EGR2, EGR3, FOS, FOSB, JUNB and JUND. These seven nodes comprise a tightly co-expressed subgraph of Community 38 and are well-known players in cancer signaling (<xref rid="B59" ref-type="bibr">59</xref>,<xref rid="B60" ref-type="bibr">60</xref>).</p>
        <p>NR4A2 methylation and KLF6 methylation are both degree-one nodes in Community 38; their only edges indicate negative partial correlation with their own expression. It may be that differential methylation of NR4A2 and KLF6 drives subtype-specific activity in the pathways of this community by modulating the expression of NR4A2 and KLF6, which are connected via FOS and JUN expression to the eight-node cluster of coexpressed TFs. In comparing these nodes between subtypes, we found that both KLF6 and NR4A2 are significantly differentially methylated (KLF6: Kruskal–Wallis chi-squared = 93.04, df = 4, <italic toggle="yes">P</italic> &lt; 2.2 × 10<sup>−16</sup>; NR4A2: Kruskal–Wallis chi-squared = 17.98, df = 4, <italic toggle="yes">p</italic> = 0.001; Supplementary Figure S19). To provide a benchmark for differential methylation between subtypes, we performed the same statistical test for a ‘housekeeping’ transcription factor (ATF1), which showed no significant difference in methylation (Kruskal–Wallis chi-squared = 6.62, df = 4, <italic toggle="yes">p</italic> = 0.158; Supplementary Figure S19), indicating that the differential methylation of these key transcription factors may play a substantial role in breast cancer beyond those already discussed, particularly given their association with the EGR/FOS/JUN expression cluster and the importance of these transcription factors in a wide range of cancer processes.</p>
      </sec>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="SEC4">
    <title>CONCLUSION AND SUMMARY</title>
    <p>Regulation of transcriptional processes in the cell involve multiple interacting partners that include transcription factors and their expression, regulation of their targets, and epigenetic factors such as DNA methylation that may enhance or disrupt regulatory interactions. Simple measures such as correlation fail to capture meaningful regulatory associations and can be dominated by spurious correlations between genes that are expressed at relatively low levels or that exhibit similar patterns of expression due to factors unrelated to the biological state of the system. Partial correlation analysis allows better discrimination between potentially causal associations between regulators and their regulatory targets and may lead to greater insight into the underlying biology of the systems we choose to study. The problem in conducting such an analysis is that different types of omics data often present with different scales, biases, and error distributions.</p>
    <p>DRAGON is a partial correlation framework optimized for the integration of multiple ‘layers’ of omics data into a unified association network that allows us to understand both associations between biological variables such as gene expression and the potential drivers of the observed correlations. DRAGON is based on Gaussian Graphical Models (GGMs) and uses a regularization scheme to optimize the trade-off between the network’s complexity and its estimation accuracy while explicitly taking into account the distinct data characteristics of the various omics data types used in the model. DRAGON accounts for differences in edge densities and feature sizes, enabling improved estimation of partial correlations compared to layer-agnostic GGMs. The advantages of DRAGON are particularly evident in simulations when the number of variables <italic toggle="yes">p</italic> is the same order of magnitude or exceeds the sample size <italic toggle="yes">n</italic>, as is the case in nearly all omics experiments.</p>
    <p>We recognize that DRAGON has some limitations. DRAGON’s GGM framework assumes multivariate normally distributed data which, for biological data, generally does not hold. For continuous distributions, data transformations such as the nonparanormal transformation (<xref rid="B33" ref-type="bibr">33</xref>) can be used to adjust input data to be approximately normally distributed; this approach, for example, allowed us to use DRAGON with methylation and gene expression data. However, other omics data types such as single-nucleotide polymorphism (SNP) data are categorical or ordinal, and alternative methods are needed to build these important regulatory elements into the DRAGON framework. Extending DRAGON to Mixed Graphical Models (<xref rid="B61" ref-type="bibr">61</xref>,<xref rid="B62" ref-type="bibr">62</xref>), which incorporate both continuous and discrete variables, could allow us to overcome this limitation of the current implementation.</p>
    <p>It is also worth noting that DRAGON does not incorporate pre-defined network structures. Structured probabilistic graphical models have been studied fairly extensively (<xref rid="B63" ref-type="bibr">63–66</xref>) as they allow users to bias networks towards a given structure consistent with biological prior knowledge. Work by our group and others has demonstrated the power of introducing soft, knowledge-based constraints into optimization problems such as gene regulatory network inference (<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B67" ref-type="bibr">67</xref>). In the case of DRAGON, this could be achieved by <italic toggle="yes">a priori</italic> removing edges from the model based on known regulatory relationships by, for example, estimating the inverse biased covariance matrix with <italic toggle="yes">a priori</italic> specified zero entries (<xref rid="B68" ref-type="bibr">68</xref>). Alternatively, one could construct a model in which ‘established’ associations between elements are more likely to be included into the network by shifting their weights at initiation (<xref rid="B64" ref-type="bibr">64</xref>) or through the use of modified target matrices <italic toggle="yes">T</italic><sup>(<italic toggle="yes">k</italic>)</sup> in Equation (<xref rid="M3" ref-type="disp-formula">3</xref>). Both approaches, alone or in combination, would need to be carefully tested taking into account the effect that a bias on the network structure has on estimates of significance levels.</p>
    <p>Although DRAGON represents an important step forward given our ability to collect increasingly large, multi-omic data sets, it is important to recognize that many problems in network inference are not addressed by DRAGON. Partial correlation relies on the data we have available, and many regulatory data types simply cannot be collected simultaneously and so remain hidden. Such hidden variables can lead to spurious associations and hamper the interpretation of networks in general. New technologies may provide additional omics layers, but integration of these will require additional methodological advances and the development of robust and scalable computational models.</p>
    <p>Second, conditional independence is only one way to model associations in biological data. Conditional independence relationships encode the factorization properties of probability distributions and while appealing as a model, it is difficult to state definitively how this concept maps to the complexity of regulatory processes in biological systems. However, the same limitation holds for all measures of ‘relatedness’, comprising mutual exclusivity (<xref rid="B9" ref-type="bibr">9</xref>) and multivariate information measures (<xref rid="B69" ref-type="bibr">69</xref>). Elucidation of which type of similarity measure is most appropriate for inference of networks from biological data remains an open challenge (<xref rid="B70" ref-type="bibr">70</xref>), but probabilistic graphical models have been shown to perform well relative to other approaches (see the lasso regression methods in (<xref rid="B70" ref-type="bibr">70</xref>) as an example). To give a clear answer, experimental data together with the corresponding ground truth is optimally needed, but our use of inference methods underlies our present inability to determine the true regulatory processes that drive biological states. Consequently, method comparison of probabilistic graphical models that allows us to specify appropriate benchmarks with respect to edge recovery, maximum likelihood, and false discovery rate are the best available methods for testing the basic process of network inference and modeling, and assessment of biological insight gained trough model analysis remains a key element of validating new methods. On both accounts, DRAGON performs well giving limited data sets that reflect those typically available in omics studies of human health and disease. We also note that our analysis focused on observational data only, and the inferred networks are undirected. Statements on causality from observational data are difficult given correlation-based models, although it is possible to provide lower bounds on causal effects (<xref rid="B71" ref-type="bibr">71</xref>). However, our biological understanding of cause and effect can guide us, at least in part. Nevertheless, additional work needs to be done to address causality in the context of multi-omics and the use of structured approaches that incorporate prior causal knowledge may be an important next step. A simple adherence to the ‘central dogma of molecular biology,’ that DNA makes RNA, and RNA makes protein, could assist in defining causal relationships. Importantly, specifying a prior belief should not prohibit the inference of more complex regulatory mechanisms contradicting these beliefs: otherwise, we stand to discover only what we already know.</p>
    <p>DRAGON represents a significant contribution to network inference by presenting a framework for modeling of partial correlations across multiple layers of omics data. DRAGON-estimated networks provide new insights into regulatory processes that may be overlooked by other methods as they are capable of identifying direct multi-omic relationships via a Gaussian graphical model framework. DRAGON is easy to use and freely available as open source software in the Network Zoo package (netZooPy v0.8; netzoo.github.io).</p>
  </sec>
  <sec sec-type="data-availability" id="SEC5">
    <title>DATA AVAILABILITY</title>
    <p>DRAGON is available through the Network Zoo package (netZooPy v0.8; netzoo.github.io) and a vignette to demonstrate its use can be found in netBooks (netbooks.networkmedicine.org). Both are also available as supplementary material. Code to reproduce the TCGA breast cancer methylation analysis is available on Github at <ext-link xlink:href="https://github.com/katehoffshutta/DRAGON-TCGA-BRCA" ext-link-type="uri">https://github.com/katehoffshutta/DRAGON-TCGA-BRCA</ext-link> (doi:10.5281/zenodo.7336963).</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkac1157_Supplemental_Files</label>
      <media xlink:href="gkac1157_supplemental_files.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p>The results shown here are in whole or part based upon data generated by the TCGA Research Network: <ext-link xlink:href="https://www.cancer.gov/tcga" ext-link-type="uri">https://www.cancer.gov/tcga</ext-link>.</p>
  </ack>
  <sec id="SEC6">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkac1157#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC7">
    <title>FUNDING</title>
    <p>National Heart, Lung, and Blood Institute of the US National Institutes of Health [2T32HL007427 to K.H.S.]; US National Cancer Institute [1R35CA220523, 1U24CA231846 to D.W., R.B., M.B.G., J.Q., M.A.]; US National Institutes of Health [R01HG011393, P01114501 to D.L.D.]; the work of H.U.Z. and M.A. was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept [01ZX1912A, 01ZX1912C].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <notes id="NT1">
    <title>Notes</title>
    <p>Present address: Deborah Weighill, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</p>
  </notes>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stelzl</surname><given-names>U.</given-names></string-name>, <string-name><surname>Worm</surname><given-names>U.</given-names></string-name>, <string-name><surname>Lalowski</surname><given-names>M.</given-names></string-name>, <string-name><surname>Haenig</surname><given-names>C.</given-names></string-name>, <string-name><surname>Brembeck</surname><given-names>F.H.</given-names></string-name>, <string-name><surname>Goehler</surname><given-names>H.</given-names></string-name>, <string-name><surname>Stroedicke</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zenkner</surname><given-names>M.</given-names></string-name>, <string-name><surname>Schoenherr</surname><given-names>A.</given-names></string-name>, <string-name><surname>Koeppen</surname><given-names>S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A human protein-protein interaction network: a resource for annotating the proteome</article-title>. <source>Cell</source>. <year>2005</year>; <volume>122</volume>:<fpage>957</fpage>–<lpage>968</lpage>.<pub-id pub-id-type="pmid">16169070</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rual</surname><given-names>J.-F.</given-names></string-name>, <string-name><surname>Venkatesan</surname><given-names>K.</given-names></string-name>, <string-name><surname>Hao</surname><given-names>T.</given-names></string-name>, <string-name><surname>Hirozane-Kishikawa</surname><given-names>T.</given-names></string-name>, <string-name><surname>Dricot</surname><given-names>A.</given-names></string-name>, <string-name><surname>Li</surname><given-names>N.</given-names></string-name>, <string-name><surname>Berriz</surname><given-names>G.F.</given-names></string-name>, <string-name><surname>Gibbons</surname><given-names>F.D.</given-names></string-name>, <string-name><surname>Dreze</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ayivi-Guedehoussou</surname><given-names>N.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Towards a proteome-scale map of the human protein–protein interaction network</article-title>. <source>Nature</source>. <year>2005</year>; <volume>437</volume>:<fpage>1173</fpage>–<lpage>1178</lpage>.<pub-id pub-id-type="pmid">16189514</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Szklarczyk</surname><given-names>D.</given-names></string-name>, <string-name><surname>Gable</surname><given-names>A.L.</given-names></string-name>, <string-name><surname>Lyon</surname><given-names>D.</given-names></string-name>, <string-name><surname>Junge</surname><given-names>A.</given-names></string-name>, <string-name><surname>Wyder</surname><given-names>S.</given-names></string-name>, <string-name><surname>Huerta-Cepas</surname><given-names>J.</given-names></string-name>, <string-name><surname>Simonovic</surname><given-names>M.</given-names></string-name>, <string-name><surname>Doncheva</surname><given-names>N.T.</given-names></string-name>, <string-name><surname>Morris</surname><given-names>J.H.</given-names></string-name>, <string-name><surname>Bork</surname><given-names>P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</article-title>. <source>Nucleic Acids Res.</source><year>2019</year>; <volume>47</volume>:<fpage>D607</fpage>–<lpage>D613</lpage>.<pub-id pub-id-type="pmid">30476243</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Markowetz</surname><given-names>F.</given-names></string-name>, <string-name><surname>Spang</surname><given-names>R.</given-names></string-name></person-group><article-title>Inferring cellular networks–a review</article-title>. <source>BMC Bioinformatics</source>. <year>2007</year>; <volume>8</volume>:<fpage>S5</fpage>.</mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Glass</surname><given-names>K.</given-names></string-name>, <string-name><surname>Huttenhower</surname><given-names>C.</given-names></string-name>, <string-name><surname>Quackenbush</surname><given-names>J.</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>G.C.</given-names></string-name></person-group><article-title>Passing messages between biological networks to refine predicted interactions</article-title>. <source>PLoS One</source>. <year>2013</year>; <volume>8</volume>:<fpage>e64832</fpage>.<pub-id pub-id-type="pmid">23741402</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aoki</surname><given-names>K.</given-names></string-name>, <string-name><surname>Ogata</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Shibata</surname><given-names>D.</given-names></string-name></person-group><article-title>Approaches for extracting practical information from gene co-expression networks in plant biology</article-title>. <source>Plant Cell Physiol.</source><year>2007</year>; <volume>48</volume>:<fpage>381</fpage>–<lpage>390</lpage>.<pub-id pub-id-type="pmid">17251202</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Altenbuchinger</surname><given-names>M.</given-names></string-name>, <string-name><surname>Weihs</surname><given-names>A.</given-names></string-name>, <string-name><surname>Quackenbush</surname><given-names>J.</given-names></string-name>, <string-name><surname>Grabe</surname><given-names>H.J.</given-names></string-name>, <string-name><surname>Zacharias</surname><given-names>H.U.</given-names></string-name></person-group><article-title>Gaussian and Mixed Graphical Models as (multi-) omics data analysis tools</article-title>. <source>Biochim. Biophys. Acta (BBA)-Gene Regul. Mech.</source><year>2020</year>; <volume>1863</volume>:<fpage>194418</fpage>.</mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aldrich</surname><given-names>J.</given-names></string-name></person-group><article-title>Correlations genuine and spurious in Pearson and Yule</article-title>. <source>Stat. Sci.</source><year>1995</year>; <volume>10</volume>:<fpage>364</fpage>–<lpage>376</lpage>.</mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Margolin</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Nemenman</surname><given-names>I.</given-names></string-name>, <string-name><surname>Basso</surname><given-names>K.</given-names></string-name>, <string-name><surname>Wiggins</surname><given-names>C.</given-names></string-name>, <string-name><surname>Stolovitzky</surname><given-names>G.</given-names></string-name>, <string-name><surname>Dalla Favera</surname><given-names>R.</given-names></string-name>, <string-name><surname>Califano</surname><given-names>A.</given-names></string-name></person-group><article-title>ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context</article-title>. <source>BMC Bioinformatics</source>. <year>2006</year>; <volume>7</volume>(<issue>Suppl. 1</issue>):<fpage>S7</fpage>.</mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Butte</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Kohane</surname><given-names>I.S.</given-names></string-name></person-group><article-title>Mutual information relevance networks: functional genomic clustering using pairwise entropy measurements</article-title>. <source>Biocomputing 2000</source>. <year>1999</year>; <publisher-name>World Scientific</publisher-name><fpage>418</fpage>–<lpage>429</lpage>.</mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wille</surname><given-names>A.</given-names></string-name>, <string-name><surname>Zimmermann</surname><given-names>P.</given-names></string-name>, <string-name><surname>Vranová</surname><given-names>E.</given-names></string-name>, <string-name><surname>Fürholz</surname><given-names>A.</given-names></string-name>, <string-name><surname>Laule</surname><given-names>O.</given-names></string-name>, <string-name><surname>Bleuler</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hennig</surname><given-names>L.</given-names></string-name>, <string-name><surname>Prelić</surname><given-names>A.</given-names></string-name>, <string-name><surname>von Rohr</surname><given-names>P.</given-names></string-name>, <string-name><surname>Thiele</surname><given-names>L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Sparse graphical Gaussian modeling of the isoprenoid gene network in Arabidopsis thaliana</article-title>. <source>Genome Biol.</source><year>2004</year>; <volume>5</volume>:<fpage>R92</fpage>.<pub-id pub-id-type="pmid">15535868</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schäfer</surname><given-names>J.</given-names></string-name>, <string-name><surname>Strimmer</surname><given-names>K.</given-names></string-name></person-group><article-title>A shrinkage approach to large-scale covariance matrix estimation and implications for functional genomics</article-title>. <source>Stat. Appl. Genet. Mol. Biol.</source><year>2005</year>; <volume>4</volume>:<fpage>Article32</fpage>.<pub-id pub-id-type="pmid">16646851</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Krumsiek</surname><given-names>J.</given-names></string-name>, <string-name><surname>Suhre</surname><given-names>K.</given-names></string-name>, <string-name><surname>Illig</surname><given-names>T.</given-names></string-name>, <string-name><surname>Adamski</surname><given-names>J.</given-names></string-name>, <string-name><surname>Theis</surname><given-names>F.J.</given-names></string-name></person-group><article-title>Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data</article-title>. <source>BMC Syst. Biol.</source><year>2011</year>; <volume>5</volume>:<fpage>21</fpage>.<pub-id pub-id-type="pmid">21281499</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ghanbari</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lasserre</surname><given-names>J.</given-names></string-name>, <string-name><surname>Vingron</surname><given-names>M.</given-names></string-name></person-group><article-title>The Distance Precision Matrix: computing networks from non-linear relationships</article-title>. <source>Bioinformatics</source>. <year>2019</year>; <volume>35</volume>:<fpage>1009</fpage>–<lpage>1017</lpage>.<pub-id pub-id-type="pmid">30165509</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cao</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cusanovich</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Ramani</surname><given-names>V.</given-names></string-name>, <string-name><surname>Aghamirzaie</surname><given-names>D.</given-names></string-name>, <string-name><surname>Pliner</surname><given-names>H.A.</given-names></string-name>, <string-name><surname>Hill</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Daza</surname><given-names>R.M.</given-names></string-name>, <string-name><surname>McFaline-Figueroa</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Packer</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Christiansen</surname><given-names>L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Joint profiling of chromatin accessibility and gene expression in thousands of single cells</article-title>. <source>Science</source>. <year>2018</year>; <volume>361</volume>:<fpage>1380</fpage>–<lpage>1385</lpage>.<pub-id pub-id-type="pmid">30166440</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Meinshausen</surname><given-names>N.</given-names></string-name>, <string-name><surname>Bühlmann</surname><given-names>P.</given-names></string-name></person-group><article-title>High-dimensional graphs and variable selection with the lasso</article-title>. <source>Annals Stat.</source><year>2006</year>; <volume>34</volume>:<fpage>1436</fpage>–<lpage>1462</lpage>.</mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Friedman</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hastie</surname><given-names>T.</given-names></string-name>, <string-name><surname>Tibshirani</surname><given-names>R.</given-names></string-name></person-group><article-title>Sparse inverse covariance estimation with the graphical lasso</article-title>. <source>Biostatistics</source>. <year>2008</year>; <volume>9</volume>:<fpage>432</fpage>–<lpage>441</lpage>.<pub-id pub-id-type="pmid">18079126</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Lauritzen</surname><given-names>S.L.</given-names></string-name></person-group><source>Graphical Models</source>. <year>1996</year>; <volume>17</volume>:<publisher-loc>Oxford</publisher-loc><publisher-name>Clarendon Press</publisher-name>.</mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Bishop</surname><given-names>C.M.</given-names></string-name></person-group><source>Pattern Recognition and Machine Learning</source>. <year>2006</year>; <publisher-loc>NY</publisher-loc><publisher-name>Springer</publisher-name>.</mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ledoit</surname><given-names>O.</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>M.</given-names></string-name></person-group><article-title>A well conditioned estimator for large dimensional covariance matrices</article-title>. <source>J. Multi. Anal.</source><year>2004</year>; <volume>88</volume>:<fpage>365</fpage>–<lpage>411</lpage>.</mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bernal</surname><given-names>V.</given-names></string-name>, <string-name><surname>Bischoff</surname><given-names>R.</given-names></string-name>, <string-name><surname>Guryev</surname><given-names>V.</given-names></string-name>, <string-name><surname>Grzegorczyk</surname><given-names>M.</given-names></string-name>, <string-name><surname>Horvatovich</surname><given-names>P.</given-names></string-name></person-group><article-title>Exact hypothesis testing for shrinkage-based Gaussian graphical models</article-title>. <source>Bioinformatics</source>. <year>2019</year>; <volume>35</volume>:<fpage>5011</fpage>–<lpage>5017</lpage>.<pub-id pub-id-type="pmid">31077287</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Benjamini</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Hochberg</surname><given-names>Y.</given-names></string-name></person-group><article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing</article-title>. <source>J. Roy. Stat. Soc.: Series B (Methodological)</source>. <year>1995</year>; <volume>57</volume>:<fpage>289</fpage>–<lpage>300</lpage>.</mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Schaefer</surname><given-names>J.</given-names></string-name>, <string-name><surname>Opgen-Rhein</surname><given-names>R.</given-names></string-name>, <string-name><surname>Strimmer</surname><given-names>K.</given-names></string-name></person-group><article-title>GeneNet: Modeling and Inferring Gene Networks R package version 1.2.16</article-title>. <year>2021</year>; <uri xlink:href="https://CRAN.R-project.org/package=GeneNet">https://CRAN.R-project.org/package=GeneNet</uri>.</mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schäfer</surname><given-names>J.</given-names></string-name>, <string-name><surname>Strimmer</surname><given-names>K.</given-names></string-name></person-group><article-title>An empirical Bayes approach to inferring large-scale gene association networks</article-title>. <source>Bioinformatics</source>. <year>2005</year>; <volume>21</volume>:<fpage>754</fpage>–<lpage>764</lpage>.<pub-id pub-id-type="pmid">15479708</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ren</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>T.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>C.-H.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>H.H.</given-names></string-name></person-group><article-title>Asymptotic normality and optimalities in estimation of large Gaussian graphical models</article-title>. <source>Annals Stat.</source><year>2015</year>; <volume>43</volume>:<fpage>991</fpage>–<lpage>1026</lpage>.</mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Janková</surname><given-names>J.</given-names></string-name>, <string-name><surname>van de Geer</surname><given-names>S.</given-names></string-name></person-group><article-title>Honest confidence regions and optimality in high-dimensional precision matrix estimation</article-title>. <source>Test</source>. <year>2017</year>; <volume>26</volume>:<fpage>143</fpage>–<lpage>162</lpage>.</mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jankova</surname><given-names>J.</given-names></string-name>, <string-name><surname>Van De Geer</surname><given-names>S.</given-names></string-name></person-group><article-title>Confidence intervals for high-dimensional inverse covariance estimation</article-title>. <source>Elect. J. Stat.</source><year>2015</year>; <volume>9</volume>:<fpage>1205</fpage>–<lpage>1229</lpage>.</mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>W.-Y.</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>S.-D.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>H.-Y.</given-names></string-name>, <string-name><surname>Sun</surname><given-names>Y.-M.</given-names></string-name>, <string-name><surname>Chou</surname><given-names>C.-H.</given-names></string-name>, <string-name><surname>Weng</surname><given-names>S.-L.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>H.-D.</given-names></string-name></person-group><article-title>MethHC: a database of DNA methylation and gene expression in human cancer</article-title>. <source>Nucleic Acids Res.</source><year>2014</year>; <volume>43</volume>:<fpage>D856</fpage>–<lpage>D861</lpage>.<pub-id pub-id-type="pmid">25398901</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tomczak</surname><given-names>K.</given-names></string-name>, <string-name><surname>Czerwińska</surname><given-names>P.</given-names></string-name>, <string-name><surname>Wiznerowicz</surname><given-names>M.</given-names></string-name></person-group><article-title>The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge</article-title>. <source>Contemp. Oncol.</source><year>2015</year>; <volume>19</volume>:<fpage>A68</fpage>.</mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lambert</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Jolma</surname><given-names>A.</given-names></string-name>, <string-name><surname>Campitelli</surname><given-names>L.F.</given-names></string-name>, <string-name><surname>Das</surname><given-names>P.K.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Albu</surname><given-names>M.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>X.</given-names></string-name>, <string-name><surname>Taipale</surname><given-names>J.</given-names></string-name>, <string-name><surname>Hughes</surname><given-names>T.R.</given-names></string-name>, <string-name><surname>Weirauch</surname><given-names>M.T.</given-names></string-name></person-group><article-title>The human transcription factors</article-title>. <source>Cell</source>. <year>2018</year>; <volume>172</volume>:<fpage>650</fpage>–<lpage>665</lpage>.<pub-id pub-id-type="pmid">29425488</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Grossman</surname><given-names>R.L.</given-names></string-name>, <string-name><surname>Heath</surname><given-names>A.P.</given-names></string-name>, <string-name><surname>Ferretti</surname><given-names>V.</given-names></string-name>, <string-name><surname>Varmus</surname><given-names>H.E.</given-names></string-name>, <string-name><surname>Lowy</surname><given-names>D.R.</given-names></string-name>, <string-name><surname>Kibbe</surname><given-names>W.A.</given-names></string-name>, <string-name><surname>Staudt</surname><given-names>L.M.</given-names></string-name></person-group><article-title>Toward a shared vision for cancer genomic data</article-title>. <source>N. Engl. J. Med.</source><year>2016</year>; <volume>375</volume>:<fpage>1109</fpage>–<lpage>1112</lpage>.<pub-id pub-id-type="pmid">27653561</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname><given-names>W.</given-names></string-name>, <string-name><surname>Triche</surname><given-names>T.J.</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Laird</surname><given-names>P.W.</given-names></string-name>, <string-name><surname>Shen</surname><given-names>H.</given-names></string-name></person-group><article-title>SeSAMe: reducing artifactual detection of DNA methylation by Infinium BeadChips in genomic deletions</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>e123</fpage>.<pub-id pub-id-type="pmid">30085201</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Lafferty</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wasserman</surname><given-names>L.</given-names></string-name></person-group><article-title>The nonparanormal: Semiparametric estimation of high dimensional undirected graphs</article-title>. <source>J. Mach. Learn. Res.</source><year>2009</year>; <volume>10</volume>:<fpage>2295</fpage>–<lpage>2328</lpage>.</mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dobin</surname><given-names>A.</given-names></string-name>, <string-name><surname>Davis</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Schlesinger</surname><given-names>F.</given-names></string-name>, <string-name><surname>Drenkow</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zaleski</surname><given-names>C.</given-names></string-name>, <string-name><surname>Jha</surname><given-names>S.</given-names></string-name>, <string-name><surname>Batut</surname><given-names>P.</given-names></string-name>, <string-name><surname>Chaisson</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gingeras</surname><given-names>T.R.</given-names></string-name></person-group><article-title>STAR: ultrafast universal RNA-seq aligner</article-title>. <source>Bioinformatics</source>. <year>2013</year>; <volume>29</volume>:<fpage>15</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="pmid">23104886</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Moore</surname><given-names>L.D.</given-names></string-name>, <string-name><surname>Le</surname><given-names>T.</given-names></string-name>, <string-name><surname>Fan</surname><given-names>G.</given-names></string-name></person-group><article-title>DNA methylation and its basic function</article-title>. <source>Neuropsychopharmacology</source>. <year>2013</year>; <volume>38</volume>:<fpage>23</fpage>–<lpage>38</lpage>.<pub-id pub-id-type="pmid">22781841</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Kulis</surname><given-names>M.</given-names></string-name>, <string-name><surname>Esteller</surname><given-names>M.</given-names></string-name></person-group><person-group person-group-type="editor"><string-name><surname>Herceg</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Ushijima</surname><given-names>T.</given-names></string-name></person-group><article-title>2 - DNA Methylation and Cancer</article-title>. <source>Epigenetics and Cancer, Part A, Vol. 70 of Advances in Genetics</source>. <year>2010</year>; <publisher-name>Academic Press</publisher-name><fpage>27</fpage>–<lpage>56</lpage>.</mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hirasawa</surname><given-names>R.</given-names></string-name>, <string-name><surname>Feil</surname><given-names>R.</given-names></string-name></person-group><article-title>A KRAB domain zinc finger protein in imprinting and disease</article-title>. <source>Dev. Cell</source>. <year>2008</year>; <volume>15</volume>:<fpage>487</fpage>–<lpage>488</lpage>.<pub-id pub-id-type="pmid">18854130</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Strogantsev</surname><given-names>R.</given-names></string-name>, <string-name><surname>Takahashi</surname><given-names>N.</given-names></string-name>, <string-name><surname>Kazachenka</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lorincz</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Hemberger</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ferguson-Smith</surname><given-names>A.C.</given-names></string-name></person-group><article-title>ZFP57 regulation of transposable elements and gene expression within and beyond imprinted domains</article-title>. <source>Epigenet. Chromatin</source>. <year>2019</year>; <volume>12</volume>:<fpage>49</fpage>.</mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mackay</surname><given-names>D.J.</given-names></string-name>, <string-name><surname>Callaway</surname><given-names>J.L.</given-names></string-name>, <string-name><surname>Marks</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>White</surname><given-names>H.E.</given-names></string-name>, <string-name><surname>Acerini</surname><given-names>C.L.</given-names></string-name>, <string-name><surname>Boonen</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Dayanikli</surname><given-names>P.</given-names></string-name>, <string-name><surname>Firth</surname><given-names>H.V.</given-names></string-name>, <string-name><surname>Goodship</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Haemers</surname><given-names>A.P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57</article-title>. <source>Nat. Genet.</source><year>2008</year>; <volume>40</volume>:<fpage>949</fpage>–<lpage>951</lpage>.<pub-id pub-id-type="pmid">18622393</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takahashi</surname><given-names>N.</given-names></string-name>, <string-name><surname>Coluccio</surname><given-names>A.</given-names></string-name>, <string-name><surname>Thorball</surname><given-names>C.W.</given-names></string-name>, <string-name><surname>Planet</surname><given-names>E.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Offner</surname><given-names>S.</given-names></string-name>, <string-name><surname>Turelli</surname><given-names>P.</given-names></string-name>, <string-name><surname>Imbeault</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ferguson-Smith</surname><given-names>A.C.</given-names></string-name>, <string-name><surname>Trono</surname><given-names>D.</given-names></string-name></person-group><article-title>ZNF445 is a primary regulator of genomic imprinting</article-title>. <source>Genes Dev.</source><year>2019</year>; <volume>33</volume>:<fpage>49</fpage>–<lpage>54</lpage>.<pub-id pub-id-type="pmid">30602440</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chen</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Xie</surname><given-names>H.</given-names></string-name>, <string-name><surname>Yao</surname><given-names>N.</given-names></string-name>, <string-name><surname>Xia</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>G.</given-names></string-name>, <string-name><surname>Qian</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ge</surname><given-names>H.</given-names></string-name>, <string-name><surname>Cui</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>ZFP57 suppress proliferation of breast cancer cells through down-regulation of MEST-mediated Wnt/β-catenin signalling pathway</article-title>. <source>Cell Death Dis.</source><year>2019</year>; <volume>10</volume>:<fpage>169</fpage>.<pub-id pub-id-type="pmid">30787268</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cheng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>R.</given-names></string-name>, <string-name><surname>Li</surname><given-names>L.</given-names></string-name>, <string-name><surname>Mu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>F.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zeng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Disruption of ZNF334 promotes triple-negative breast carcinoma malignancy through the SFRP1/Wnt/β-catenin signaling axis</article-title>. <source>Cell. Mol. Life Sci.</source><year>2022</year>; <volume>79</volume>:<fpage>280</fpage>.<pub-id pub-id-type="pmid">35507080</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sun</surname><given-names>D.</given-names></string-name>, <string-name><surname>Gan</surname><given-names>X.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>L.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ding</surname><given-names>D.</given-names></string-name>, <string-name><surname>Li</surname><given-names>W.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ding</surname><given-names>W.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>L.</given-names></string-name>, <string-name><surname>Hou</surname><given-names>G.</given-names></string-name><etal>et al</etal>.</person-group><article-title>DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334</article-title>. <source>Cell Death Dis.</source><year>2022</year>; <volume>13</volume>:<fpage>446</fpage>.<pub-id pub-id-type="pmid">35534462</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ye</surname><given-names>H.</given-names></string-name>, <string-name><surname>Duan</surname><given-names>M.</given-names></string-name></person-group><article-title>Downregulation of FOXO6 in breast cancer promotes epithelial–mesenchymal transition and facilitates migration and proliferation of cancer cells</article-title>. <source>Cancer Manage. Res.</source><year>2018</year>; <volume>10</volume>:<fpage>5145</fpage>.</mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>X.</given-names></string-name>, <string-name><surname>Mao</surname><given-names>X.</given-names></string-name>, <string-name><surname>Shi</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>B.</given-names></string-name>, <string-name><surname>Xie</surname><given-names>L.</given-names></string-name>, <string-name><surname>Di</surname><given-names>S.</given-names></string-name>, <string-name><surname>Jin</surname><given-names>L.</given-names></string-name></person-group><article-title>Knockdown of FOXO6 inhibits glycolysis and reduces cell resistance to paclitaxel in HCC cells via PI3K/Akt signaling pathway</article-title>. <source>OncoTargets Ther.</source><year>2020</year>; <volume>13</volume>:<fpage>1545</fpage>.</mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Da Silveira</surname><given-names>W.</given-names></string-name>, <string-name><surname>Palma</surname><given-names>P.</given-names></string-name>, <string-name><surname>Sicchieri</surname><given-names>R.</given-names></string-name>, <string-name><surname>Villacis</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Mandarano</surname><given-names>L.</given-names></string-name>, <string-name><surname>Oliveira</surname><given-names>T.</given-names></string-name>, <string-name><surname>Antonio</surname><given-names>H.</given-names></string-name>, <string-name><surname>Andrade</surname><given-names>J. M.d.</given-names></string-name>, <string-name><surname>Muglia</surname><given-names>V.F.</given-names></string-name>, <string-name><surname>Rogatto</surname><given-names>S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Transcription factor networks derived from breast cancer stem cells control the immune response in the basal subtype</article-title>. <source>Sci. Rep.</source><year>2017</year>; <volume>7</volume>:<fpage>2851</fpage>.<pub-id pub-id-type="pmid">28588211</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zou</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>B.</given-names></string-name>, <string-name><surname>Li</surname><given-names>L.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Tang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Jing</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Chi</surname><given-names>T.</given-names></string-name></person-group><article-title>IKZF3 deficiency potentiates chimeric antigen receptor T cells targeting solid tumors</article-title>. <source>Cancer Lett.</source><year>2022</year>; <volume>524</volume>:<fpage>121</fpage>–<lpage>130</lpage>.<pub-id pub-id-type="pmid">34687790</pub-id></mixed-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sato</surname><given-names>N.</given-names></string-name>, <string-name><surname>Kondo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Arai</surname><given-names>K.-i.</given-names></string-name></person-group><article-title>The orphan nuclear receptor GCNF recruits DNA methyltransferase for Oct-3/4 silencing</article-title>. <source>Biochem. Biophys. Res. Commun.</source><year>2006</year>; <volume>344</volume>:<fpage>845</fpage>–<lpage>851</lpage>.<pub-id pub-id-type="pmid">16631596</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Okano</surname><given-names>M.</given-names></string-name>, <string-name><surname>Bell</surname><given-names>D.W.</given-names></string-name>, <string-name><surname>Haber</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Li</surname><given-names>E.</given-names></string-name></person-group><article-title>DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development</article-title>. <source>Cell</source>. <year>1999</year>; <volume>99</volume>:<fpage>247</fpage>–<lpage>257</lpage>.<pub-id pub-id-type="pmid">10555141</pub-id></mixed-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Willis</surname><given-names>S.</given-names></string-name>, <string-name><surname>De</surname><given-names>P.</given-names></string-name>, <string-name><surname>Dey</surname><given-names>N.</given-names></string-name>, <string-name><surname>Long</surname><given-names>B.</given-names></string-name>, <string-name><surname>Young</surname><given-names>B.</given-names></string-name>, <string-name><surname>Sparano</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>V.</given-names></string-name>, <string-name><surname>Davidson</surname><given-names>N.E.</given-names></string-name>, <string-name><surname>Leyland-Jones</surname><given-names>B.R.</given-names></string-name></person-group><article-title>Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs</article-title>. <source>Meta Gene</source>. <year>2015</year>; <volume>4</volume>:<fpage>129</fpage>–<lpage>141</lpage>.<pub-id pub-id-type="pmid">26005638</pub-id></mixed-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Madsen</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Knight</surname><given-names>S.</given-names></string-name>, <string-name><surname>Sweeney</surname><given-names>C.</given-names></string-name>, <string-name><surname>Factor</surname><given-names>R.</given-names></string-name>, <string-name><surname>Salama</surname><given-names>M.</given-names></string-name>, <string-name><surname>Stijleman</surname><given-names>I.J.</given-names></string-name>, <string-name><surname>Rajamanickam</surname><given-names>V.</given-names></string-name>, <string-name><surname>Welm</surname><given-names>B.E.</given-names></string-name>, <string-name><surname>Arunachalam</surname><given-names>S.</given-names></string-name>, <string-name><surname>Jones</surname><given-names>B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15</article-title>. <source>Cancer Epidemiol. Biomarkers Prev.</source><year>2018</year>; <volume>27</volume>:<fpage>644</fpage>–<lpage>652</lpage>.<pub-id pub-id-type="pmid">29650789</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <label>52.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Pons</surname><given-names>P.</given-names></string-name>, <string-name><surname>Latapy</surname><given-names>M.</given-names></string-name></person-group><person-group person-group-type="editor"><string-name><surname>Yolum</surname><given-names>P.</given-names></string-name>, <string-name><surname>Gngšr</surname><given-names>T.</given-names></string-name>, <string-name><surname>Gÿrgen</surname><given-names>F.</given-names></string-name>, <string-name><surname>Özturan</surname><given-names>C.</given-names></string-name></person-group><article-title>Computing communities in large networks using random walks</article-title>. <article-title>Computer and Information Sciences - ISCIS 2005. ISCIS 2005</article-title>. <source>Lecture Notes in Computer Science</source>. <year>2005</year>; <volume>3733</volume>:<publisher-loc>Berlin, Heidelberg</publisher-loc><publisher-name>Springer</publisher-name>.</mixed-citation>
    </ref>
    <ref id="B53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Csardi</surname><given-names>G.</given-names></string-name>, <string-name><surname>Nepusz</surname><given-names>T.</given-names></string-name></person-group><article-title>The igraph software package for complex network research</article-title>. <source>Int. J., comp. Syst.</source><year>2006</year>; <volume>1695</volume>:<fpage>1</fpage>–<lpage>9</lpage>.</mixed-citation>
    </ref>
    <ref id="B54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gillespie</surname><given-names>M.</given-names></string-name>, <string-name><surname>Jassal</surname><given-names>B.</given-names></string-name>, <string-name><surname>Stephan</surname><given-names>R.</given-names></string-name>, <string-name><surname>Milacic</surname><given-names>M.</given-names></string-name>, <string-name><surname>Rothfels</surname><given-names>K.</given-names></string-name>, <string-name><surname>Senff-Ribeiro</surname><given-names>A.</given-names></string-name>, <string-name><surname>Griss</surname><given-names>J.</given-names></string-name>, <string-name><surname>Sevilla</surname><given-names>C.</given-names></string-name>, <string-name><surname>Matthews</surname><given-names>L.</given-names></string-name>, <string-name><surname>Gong</surname><given-names>C.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The eactome pathway knowledgebase 2022</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D687</fpage>–<lpage>D692</lpage>.<pub-id pub-id-type="pmid">34788843</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <label>55.</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Korotkevich</surname><given-names>G.</given-names></string-name>, <string-name><surname>Sukhov</surname><given-names>V.</given-names></string-name>, <string-name><surname>Budin</surname><given-names>N.</given-names></string-name>, <string-name><surname>Shpak</surname><given-names>B.</given-names></string-name>, <string-name><surname>Artyomov</surname><given-names>M.N.</given-names></string-name>, <string-name><surname>Sergushichev</surname><given-names>A.</given-names></string-name></person-group><article-title>Fast gene set enrichment analysis</article-title>. <year>2021</year>; <comment>bioRxiv doi:</comment><comment>01 February 2021, preprint: not peer reviewed</comment><pub-id pub-id-type="doi">10.1101/060012</pub-id>.</mixed-citation>
    </ref>
    <ref id="B56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Woodfield</surname><given-names>G.W.</given-names></string-name>, <string-name><surname>Horan</surname><given-names>A.D.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Weigel</surname><given-names>R.J.</given-names></string-name></person-group><article-title>TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling</article-title>. <source>Cancer Res.</source><year>2007</year>; <volume>67</volume>:<fpage>8439</fpage>–<lpage>8443</lpage>.<pub-id pub-id-type="pmid">17875680</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eroles</surname><given-names>P.</given-names></string-name>, <string-name><surname>Bosch</surname><given-names>A.</given-names></string-name>, <string-name><surname>Pérez-Fidalgo</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Lluch</surname><given-names>A.</given-names></string-name></person-group><article-title>Molecular biology in breast cancer: intrinsic subtypes and signaling pathways</article-title>. <source>Cancer Treat. Rev.</source><year>2012</year>; <volume>38</volume>:<fpage>698</fpage>–<lpage>707</lpage>.<pub-id pub-id-type="pmid">22178455</pub-id></mixed-citation>
    </ref>
    <ref id="B58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Colaprico</surname><given-names>A.</given-names></string-name>, <string-name><surname>Silva</surname><given-names>T.C.</given-names></string-name>, <string-name><surname>Olsen</surname><given-names>C.</given-names></string-name>, <string-name><surname>Garofano</surname><given-names>L.</given-names></string-name>, <string-name><surname>Cava</surname><given-names>C.</given-names></string-name>, <string-name><surname>Garolini</surname><given-names>D.</given-names></string-name>, <string-name><surname>Sabedot</surname><given-names>T.S.</given-names></string-name>, <string-name><surname>Malta</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Pagnotta</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Castiglioni</surname><given-names>I.</given-names></string-name><etal>et al</etal>.</person-group><article-title>TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>e71</fpage>.<pub-id pub-id-type="pmid">26704973</pub-id></mixed-citation>
    </ref>
    <ref id="B59">
      <label>59.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>A.V.</given-names></string-name>, <string-name><surname>Cui</surname><given-names>X.</given-names></string-name>, <string-name><surname>Oesterreich</surname><given-names>S.</given-names></string-name></person-group><article-title>Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer</article-title>. <source>Clin. Cancer Res.</source><year>2001</year>; <volume>7</volume>:<fpage>4429s</fpage>–<lpage>4435s</lpage>.<pub-id pub-id-type="pmid">11916236</pub-id></mixed-citation>
    </ref>
    <ref id="B60">
      <label>60.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>H.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>G.</given-names></string-name></person-group><article-title>The role of the transcription factor EGR1 in cancer</article-title>. <source>Front. Oncol.</source><year>2021</year>; <volume>11</volume>:<fpage>775</fpage>.</mixed-citation>
    </ref>
    <ref id="B61">
      <label>61.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>J.D.</given-names></string-name>, <string-name><surname>Hastie</surname><given-names>T.J.</given-names></string-name></person-group><article-title>Learning the structure of mixed graphical models</article-title>. <source>J. Comput. Graph. Stat.</source><year>2015</year>; <volume>24</volume>:<fpage>230</fpage>–<lpage>253</lpage>.<pub-id pub-id-type="pmid">26085782</pub-id></mixed-citation>
    </ref>
    <ref id="B62">
      <label>62.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Altenbuchinger</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zacharias</surname><given-names>H.U.</given-names></string-name>, <string-name><surname>Solbrig</surname><given-names>S.</given-names></string-name>, <string-name><surname>Schäfer</surname><given-names>A.</given-names></string-name>, <string-name><surname>Büyüközkan</surname><given-names>M.</given-names></string-name>, <string-name><surname>Schultheiß</surname><given-names>U.T.</given-names></string-name>, <string-name><surname>Kotsis</surname><given-names>F.</given-names></string-name>, <string-name><surname>Köttgen</surname><given-names>A.</given-names></string-name>, <string-name><surname>Spang</surname><given-names>R.</given-names></string-name>, <string-name><surname>Oefner</surname><given-names>P.J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A multi-source data integration approach reveals novel associations between metabolites and renal outcomes in the German Chronic Kidney Disease study</article-title>. <source>Sci. Rep.</source><year>2019</year>; <volume>9</volume>:<fpage>13954</fpage>.<pub-id pub-id-type="pmid">31562371</pub-id></mixed-citation>
    </ref>
    <ref id="B63">
      <label>63.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ambroise</surname><given-names>C.</given-names></string-name>, <string-name><surname>Chiquet</surname><given-names>J.</given-names></string-name>, <string-name><surname>Matias</surname><given-names>C.</given-names></string-name></person-group><article-title>Inferring sparse Gaussian graphical models with latent structure</article-title>. <source>Elect. J. Stat.</source><year>2009</year>; <volume>3</volume>:<fpage>205</fpage>–<lpage>238</lpage>.</mixed-citation>
    </ref>
    <ref id="B64">
      <label>64.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ma</surname><given-names>J.</given-names></string-name>, <string-name><surname>Shojaie</surname><given-names>A.</given-names></string-name>, <string-name><surname>Michailidis</surname><given-names>G.</given-names></string-name></person-group><article-title>Network-based pathway enrichment analysis with incomplete network information</article-title>. <source>Bioinformatics</source>. <year>2016</year>; <volume>32</volume>:<fpage>3165</fpage>–<lpage>3174</lpage>.<pub-id pub-id-type="pmid">27357170</pub-id></mixed-citation>
    </ref>
    <ref id="B65">
      <label>65.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Siahpirani</surname><given-names>A.F.</given-names></string-name>, <string-name><surname>Roy</surname><given-names>S.</given-names></string-name></person-group><article-title>A prior-based integrative framework for functional transcriptional regulatory network inference</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>e21</fpage>.<pub-id pub-id-type="pmid">27794550</pub-id></mixed-citation>
    </ref>
    <ref id="B66">
      <label>66.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhuang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Xing</surname><given-names>F.</given-names></string-name>, <string-name><surname>Ghosh</surname><given-names>D.</given-names></string-name>, <string-name><surname>Banaei-Kashani</surname><given-names>F.</given-names></string-name>, <string-name><surname>Bowler</surname><given-names>R.P.</given-names></string-name>, <string-name><surname>Kechris</surname><given-names>K.</given-names></string-name></person-group><article-title>An Augmented High-Dimensional Graphical Lasso Method to Incorporate Prior Biological Knowledge for Global Network Learning</article-title>. <source>Front. Genet.</source><year>2022</year>; <fpage>2405</fpage>.</mixed-citation>
    </ref>
    <ref id="B67">
      <label>67.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wolpert</surname><given-names>D.H.</given-names></string-name>, <string-name><surname>Macready</surname><given-names>W.G.</given-names></string-name></person-group><article-title>No free lunch theorems for optimization</article-title>. <source>IEEE Trans. Evol. Comput.</source><year>1997</year>; <volume>1</volume>:<fpage>67</fpage>–<lpage>82</lpage>.</mixed-citation>
    </ref>
    <ref id="B68">
      <label>68.</label>
      <mixed-citation publication-type="book"><person-group person-group-type="author"><string-name><surname>Hastie</surname><given-names>T.</given-names></string-name>, <string-name><surname>Tibshirani</surname><given-names>R.</given-names></string-name>, <string-name><surname>Friedman</surname><given-names>J.H.</given-names></string-name>, <string-name><surname>Friedman</surname><given-names>J.H.</given-names></string-name></person-group><source>The Elements of Statistical Learning: Data Mining, Inference, and Prediction</source>. <year>2009</year>; <volume>2</volume>:<publisher-loc>NY</publisher-loc><publisher-name>Springer</publisher-name>.</mixed-citation>
    </ref>
    <ref id="B69">
      <label>69.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chan</surname><given-names>T.E.</given-names></string-name>, <string-name><surname>Stumpf</surname><given-names>M.P.</given-names></string-name>, <string-name><surname>Babtie</surname><given-names>A.C.</given-names></string-name></person-group><article-title>Gene regulatory network inference from single-cell data using multivariate information measures</article-title>. <source>Cell Syst.</source><year>2017</year>; <volume>5</volume>:<fpage>251</fpage>–<lpage>267</lpage>.<pub-id pub-id-type="pmid">28957658</pub-id></mixed-citation>
    </ref>
    <ref id="B70">
      <label>70.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marbach</surname><given-names>D.</given-names></string-name>, <string-name><surname>Costello</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Küffner</surname><given-names>R.</given-names></string-name>, <string-name><surname>Vega</surname><given-names>N.M.</given-names></string-name>, <string-name><surname>Prill</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Camacho</surname><given-names>D.M.</given-names></string-name>, <string-name><surname>Allison</surname><given-names>K.R.</given-names></string-name>, <string-name><surname>Kellis</surname><given-names>M.</given-names></string-name>, <string-name><surname>Collins</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Stolovitzky</surname><given-names>G.</given-names></string-name></person-group><article-title>Wisdom of crowds for robust gene network inference</article-title>. <source>Nat. Methods</source>. <year>2012</year>; <volume>9</volume>:<fpage>796</fpage>–<lpage>804</lpage>.<pub-id pub-id-type="pmid">22796662</pub-id></mixed-citation>
    </ref>
    <ref id="B71">
      <label>71.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maathuis</surname><given-names>M.H.</given-names></string-name>, <string-name><surname>Colombo</surname><given-names>D.</given-names></string-name>, <string-name><surname>Kalisch</surname><given-names>M.</given-names></string-name>, <string-name><surname>Bühlmann</surname><given-names>P.</given-names></string-name></person-group><article-title>Predicting causal effects in large-scale systems from observational data</article-title>. <source>Nat. Methods</source>. <year>2010</year>; <volume>7</volume>:<fpage>247</fpage>–<lpage>248</lpage>.<pub-id pub-id-type="pmid">20354511</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
